Advanced search
Publication Cover
Critical Reviews in Food Science and Nutrition Volume 60, 2020 - Issue 6
Submit an article Journal homepage
5,372
Views
209
CrossRef citations to date
0
Altmetric
Reviews

Cellular and molecular mechanisms of curcumin in prevention and treatment of disease

Sita Sharan PatelDepartment of Pharmacy, Sagar Institute of Research and Technology, Bhopal, India; Correspondence[email protected]
,
Ashish AcharyaDepartment of Pharmacy, Sagar Institute of Research and Technology, Bhopal, India;
,
R. S. RayPharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
,
Ritesh AgrawalDepartment of Pharmacy, Sagar Institute of Research and Technology, Bhopal, India;
,
Ramsaneh RaghuwanshiDepartment of Pharmacy, Sagar Institute of Research and Technology, Bhopal, India;
&
Priyal JainDepartment of Pharmacy, Sagar Institute of Research and Technology, Bhopal, India;
Pages 887-939 | Published online: 11 Jan 2019

References

  • Abidi, A., S. Gupta, M. Agarwal, H. Bhalla, and M. Saluja. 2014. Evaluation of efficacy of curcumin as an add-on therapy in patients of bronchial asthma. Journal of Clinical and Diagnostic Research 8:HC19–HC24.
  • Acar, A., E. Akil, H. Alp, O. Evliyaoglu, E. Kibrisli, A. Inal, F. Unan, and N. Tasdemir. 2012. Oxidative damage is ameliorated by curcumin treatment in brain and sciatic nerve of diabetic rats. International Journal of Neuroscience 122 (7):367–372. doi: 10.3109/00207454.2012.657380.
  • Adhvaryu, M. R., N. Reddy, and B. C. Vakharia. 2008. Prevention of hepatotoxicity due to anti tuberculosis treatment: A novel integrative approach. World Journal of Gastroenterology 14 (30):4753–4762.
  • Afrin, M. R., S. Arumugam, M. A. Rahman, V. Karuppagounder, M. Harima, H. Suzuki, S. Miyashita, K. Suzuki, K. Ueno, H. Yoneyama, and K. Watanabe. 2017. Curcumin reduces the risk of chronic kidney damage in mice with nonalcoholic steatohepatitis by modulating endoplasmic reticulum stress and MAPK signaling. International Immunopharmacology 49:161–167. doi: 10.1016/j.intimp.2017.05.035.
  • Agarwal, N. B., S. Jain, D. Nagpal, N. K. Agarwal, P. K. Mediratta, and K. K. Sharma. 2013. Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice. Fundamental & Clinical Pharmacology 27:169–172. doi: 10.1111/j.1472-8206.2011.01002.x.
  • Agarwal, N. B., S. Jain, N. K. Agarwal, P. K. Mediratta, and K. K. Sharma. 2011. Modulation of pentylenetetrazole-induced kindling and oxidative stress by curcumin in mice. Phytomedicine 18 (8–9):756–759. doi: 10.1016/j.phymed.2010.11.007.
  • Aggarwal, B. B., Y. J. Surh, and S. Shishodia. 2007. Biomedical and life sciences. In The molecular targets and therapeutic uses of curcumin in health and disease. Boston, MA: Springer.
  • Ahmad, M. 2013. Protective effects of curcumin against lithium-pilocarpine induced status epilepticus, cognitive dysfunction and oxidative stress in young rats. Saudi Journal of Biological Sciences 20 (2):155–162. doi: 10.1016/j.sjbs.2013.01.002.
  • Ahn, J., H. Lee, S. Kim, and T. Ha. 2010. Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/β-catenin signaling. American Journal of Physiology-Cell Physiology 298 (6):C1510–C1516. doi: 10.1152/ajpcell.00369.2009.
  • Akinyemi, A. J., G. Oboh, S. I. Oyeleye, and O. Ogunsuyi. 2017. Anti-amnestic effect of curcumin in combination with donepezil, an anticholinesterase drug: Involvement of cholinergic system. Neurotoxicity Research 31 (4):560–569.
  • Akula, K. K., and S. Kulkarni. 2014. Effect of curcumin against pentylenetetrazol‐induced seizure threshold in mice: Possible involvement of adenosine A1 receptors. Phytotherapy Research 28 (5):714–721. doi: 10.1002/ptr.5048.
  • Alappat, L., and A. B. Awad. 2010. Curcumin and obesity: Evidence and mechanisms. Nutrition Reviews 68 (12):729–738.
  • Ali, A., and A. C. Banerjea. 2016. Curcumin inhibits HIV-1 by promoting Tat protein degradation. Scientific Reports 6:27539.
  • Ali, B. H., S. Al, ‐Salam, Y. Al Suleimani, J. Al Kalbani, S. Al Bahlani, M. Ashique, P. Manoj, B. Al Zhili, N. Al Abri, and H. T. Naser. 2018. Curcumin ameliorates kidney function and oxidative stress in experimental chronic kidney disease. Basic & Clinical Pharmacology & Toxicology 122:65–73. doi: 10.1111/bcpt.12817.
  • Allegri, P., A. Mastromarino, and P. Neri. 2010. Management of chronic anterior uveitis relapses: Efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clinical Ophthalmology 4:1201–1206.
  • Altinay, S., M. Cabalar, C. Isler, F. Yildirim, D. S. Celik, O. Zengi, A. Tas, and A. Gulcubuk. 2017. Is chronic curcumin supplementation neuroprotective against ischemia for antioxidant activity, neurological deficit, or neuronal apoptosis in an experimental stroke model? Turkish Neurosurgery 27 (4):537–545.
  • Alwi, I., T. Santoso, S. Suyono, B. Sutrisna, F. D. Suyatna, S. B. Kresno, and S. Ernie. 2008. The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta Medica Indonesiana 40:201–210.
  • Anand, P., C. Sundaram, S. Jhurani, A. B. Kunnumakkara, and B. B. Aggarwal. 2008. Curcumin and cancer: An “old-age” disease with an “age-old” solution. Cancer Letters 267 (1):133–164.
  • Antiga, E., V. Bonciolini, W. Volpi, E. Del Bianco, and M. Caproni. 2015. Oral curcumin (Meriva) is effective as an adjuvant treatment and is able to reduce IL-22 serum levels in patients with psoriasis vulgaris. BioMed Research International 2015:1. doi: 10.1155/2015/283634.
  • Anwar, M., S. Akhter, N. Mallick, S. Mohapatra, S. Zafar, Rizvi M.M.A, A. Ali, and F. J. Ahmad. 2016. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies. Pharmacological Research 113:146–165.
  • Appendino, G., G. Belcaro, U. Cornelli, R. Luzzi, S. Togni, M. Dugall, M. Cesarone, B. Feragalli, E. Ippolito, and B. Errichi. 2011. Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. Panminerva Medica 53:43–49.
  • Attia, H. N., N. M. Al-Rasheed, N. M. Al-Rasheed, Y. A. Maklad, A. A. Ahmed, and S. A. B. Kenawy. 2012. Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats. Behavioural Pharmacology 23 (2):153–161.
  • Avasarala, S., F. Zhang, G. Liu, R. Wang, S. D. London, and L. London. 2013. Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome. PLoS One 8 (2):e57285. doi: 10.1371/journal.pone.0057285.
  • Bahramsoltani, R., M. H. Farzaei, M. S. Farahani, and R. Rahimi. 2015. Phytochemical constituents as future antidepressants: A comprehensive review. Reviews in the Neurosciences 26:699–719.
  • Bahramsoltani, R., R. Rahimi, and M. H. Farzaei. 2017. Pharmacokinetic interactions of curcuminoids with conventional drugs: A review. Journal of Ethnopharmacology 209:1–12.
  • Balasubramanyam, K., R. A. Varier, M. Altaf, V. Swaminathan, N. B. Siddappa, U. Ranga, and T. K. Kundu. 2004. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. Journal of Biological Chemistry 279 (49):51163–51171.
  • Baliga, M. S., N. Joseph, M. V. Venkataranganna, A. Saxena, V. Ponemone, and R. Fayad. 2012. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: Preclinical and clinical observations. Food & Function 3:1109–1117. doi: 10.1039/c2fo30097d.
  • Banerjee, B., S. Chakraborty, D. Ghosh, S. Raha, P. C. Sen, and K. Jana. 2016. Benzo (a) pyrene induced p53 mediated male germ cell apoptosis: Synergistic protective effects of curcumin and resveratrol. Frontiers in Pharmacology 7:245. doi:10.3389/fphar.2016.00245.
  • Banerjee, S., S. K. Singh, I. Chowdhury, J. W. Lillard, Jr., and R. Singh. 2017. Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer. Frontiers in Bioscience (Elite edition) 9:235–245.
  • Bangaru, M. L., S. Chen, J. Woodliff, and S. Kansra. 2010. Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells. Anticancer Research 30:499–504.
  • Barta, A., P. Janega, P. Babál, E. Murár, M. Cebová, and O. Pechánová. 2015. The effect of curcumin on liver fibrosis in the rat model of microsurgical cholestasis. Food & Function 6:2187–2193. doi: 10.1039/C5FO00176E.
  • Basha, R., S. F. Connelly, U. T. Sankpal, G. P. Nagaraju, H. Patel, J. K. Vishwanatha, S. Shelake, L. Tabor-Simecka, M. Shoji, J. W. Simecka, and B. El-Rayes. 2016. Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution. The Journal of Nutritional Biochemistry 31:77–87.
  • Baum, L., C. W. K. Lam, S. K.-K. Cheung, T. Kwok, V. Lui, J. Tsoh, L. Lam, V. Leung, E. Hui, C. Ng, et al. 2008. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. Journal of Clinical Psychopharmacology 28 (1):110–113. doi: 10.1097/jcp.0b013e318160862c.
  • Bayet-Robert, M., F. Kwiatowski, M. Leheurteur, F. Gachon, E. Planchat, C. Abrial, M. A. Mouret-Reynier, X. Durando, C. Barthomeuf, and P. Chollet. 2010. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biology & Therapy 9:8–14. doi: 10.4161/cbt.9.1.10392.
  • Begum, A. N., M. R. Jones, G. P. Lim, T. Morihara, P. Kim, D. D. Heath, C. L. Rock, M. A. Pruitt, F. Yang, B. Hudspeth, et al. 2008. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. Journal of Pharmacology and Experimental Therapeutics 326 (1):196–208. doi: 10.1124/jpet.108.137455.
  • Belcaro, G., M. R. Cesarone, M. Dugall, L. Pellegrini, A. Ledda, M. G. Grossi, S. Togni, and G. Appendino. 2010. Efficacy and safety of Meriva (R), a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Alternative Medicine Review 15:337–344.
  • Bishnoi, M., K. Chopra, L. Rongzhu, and S. K. Kulkarni. 2011. Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: Cellular and neurochemical evidence. Neurotoxicity Research 20 (3):215–225.
  • Blaslov, K. 2017. Curcumin: A polyphenol with molecular targets for diabetes control? Endocrinology and Metabolic Syndrome 3:43–48.
  • Boonla, O., U. Kukongviriyapan, P. Pakdeechote, V. Kukongviriyapan, P. Pannangpetch, P. Prachaney, and S. E. Greenwald. 2014. Curcumin improves endothelial dysfunction and vascular remodeling in 2K-1C hypertensive rats by raising nitric oxide availability and reducing oxidative stress. Nitric Oxide 42:44–53. doi: 10.1016/j.niox.2014.09.001.
  • Borges, G. Á., D. F. Rêgo, D. X. Assad, R. D. Coletta, G. De Luca Canto, and E. N. Guerra. 2017. In vivo and in vitro effects of curcumin on head and neck carcinoma: A systematic review. Journal of Oral Pathology & Medicine 46:3–20. doi: 10.1111/jop.12455.
  • Bourne, K. Z., N. Bourne, S. F. Reising, and L. R. Stanberry. 1999. Plant products as topical microbicide candidates: Assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antiviral Research 42 (3):219–226.
  • Bradford, P. G. 2013. Curcumin and obesity. Biofactors (Oxford, England) 39 (1):78–87.
  • Broskova, Z., K. Drabikova, R. Sotnikova, S. Fialova, and V. Knezl. 2013. Effect of plant polyphenols on ischemia‐reperfusion injury of the isolated rat heart and vessels. Phytotherapy Research 27:1018–1022. doi: 10.1002/ptr.4825.
  • Bulboacă A., S. D Bolboacă, and S. Suci. 2016. Protective effect of curcumin in fructose-induced metabolic syndrome and in streptozotocin-induced diabetes in rats. Iranian Journal of Basic Medical Sciences 19:585–593.
  • Bundy, R., A. F. Walker, R. W. Middleton, and J. Booth. 2004. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: A pilot study. Journal of Alternative & Complementary Medicine 10:1015–1018.
  • Burns, J., P. D. Joseph, K. J. Rose, M. M. Ryan, and R. A. Ouvrier. 2009. Effect of oral curcumin on Dejerine-Sottas disease. Pediatric Neurology 41 (4):305–308.
  • Calaf, G. M., C. Echiburú-Chau, D. Roy, Y. Chai, G. Wen, and A. S. Balajee. 2011. Protective role of curcumin in oxidative stress of breast cells. Oncology Reports 26 (4):1029–1035.
  • Campbell, V. A., and A. Gowran. 2007. Alzheimer’s disease; taking the edge off with cannabinoids? British Journal of Pharmacology 152 (5):655–662.
  • Cao, H., H. Yu, Y. Feng, L. Chen, and F. Liang. 2017. Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis. Cancer Chemotherapy and Pharmacology 79 (5):985–994. doi: 10.1007/s00280-017-3301-1.
  • Carlson, L. J., B. Cote, A. W. Alani, and D. A. Rao. 2014. Polymeric micellar co‐delivery of resveratrol and curcumin to mitigate in vitro doxorubicin‐induced cardiotoxicity. Journal of Pharmaceutical Sciences 103 (8):2315–2322.
  • Carroll, R. E., R. V. Benya, D. K. Turgeon, S. Vareed, M. Neuman, L. Rodriguez, M. Kakarala, P. M. Carpenter, C. McLaren, F. L. Meyskens, and D. E. Brenner. 2011. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prevention Research 4 (3):354–364. doi: 10.1158/1940-6207.CAPR-10-0098.
  • Chainani-Wu, N., K. Collins, and S. Silverman. 2012. Use of curcuminoids in a cohort of patients with oral lichen planus, an autoimmune disease. Phytomedicine 19 (5):418–423.
  • Chakraborty, M., A. Bhattacharjee, and J. V. Kamath. 2017. Cardioprotective effect of curcumin and piperine combination against cyclophosphamide-induced cardiotoxicity. Indian Journal of Pharmacology 49:65–70.
  • Chandran, B., and A. Goel. 2012. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytotherapy Research 26 (11):1719–1725. doi: 10.1002/ptr.4639.
  • Chauhan, P. S., D. Dash, and R. Singh. 2017. Intranasal curcumin inhibits pulmonary fibrosis by modulating matrix metalloproteinase-9 (MMP-9) in ovalbumin-induced chronic asthma. Inflammation 40 (1):248–258. doi: 10.1007/s10753-016-0475-3.
  • Chauhan, P. S., D. Dash, B. Paul, and R. Singh. 2016. Intranasal curcumin ameliorates airway inflammation and obstruction by regulating MAPKinase activation (p38, Erk and JNK) and prostaglandin D2 release in murine model of asthma. International Immunopharmacology 31:200–206.
  • Chen, C. Q., K. Yu, Q. X. Yan, C. Y. Xing, Y. Chen, Z. Yan, Y. F. Shi, K. W. Zhao, and S. M. Gao. 2013. Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class Ι histone deacetylases. Carcinogenesis 34 (7):1442–1449. doi: 10.1093/carcin/bgt070.
  • Chen, D. Y., J. H. Shien, L. Tiley, S. S. Chiou, S. Y. Wang, T. J. Chang, Y. J. Lee, K. W. Chan, and W. L. Hsu. 2010. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chemistry 119 (4):1346–1351.
  • Chen, F. Y., J. Zhou, N. Guo, W. G. Ma, X. Huang, H. Wang, and Z. Y. Yuan. 2015. Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis. Biochemical and Biophysical Research Communications 467 (4):872–878. doi: 10.1016/j.bbrc.2015.10.051.
  • Chen, H., L. Chen, L. Wang, X. Zhou, J. Y. W., Chan, J. Li, G. Cui, and S. M. Y. Lee. 2016. Synergistic effect of fenretinide and curcumin for treatment of non-small cell lung cancer. Cancer Biology & Therapy 17:1022–1029.
  • Chen, J., G. Wang, L. Wang, J. Kang, and J. Wang. 2010. Curcumin p38-dependently enhances the anticancer activity of valproic acid in human leukemia cells. European Journal of Pharmaceutical Sciences 41 (2):210–218.
  • Chen, L., T. Liu, Q. Wang, and J. Liu. 2017. Anti-inflammatory effect of combined tetramethylpyrazine, resveratrol and curcumin in vivo. BMC Complementary and Alternative Medicine 17:233. doi:10.1186/s12906-017-1739-7.
  • Chen, M. H., M. Y. Lee, J. J. Chuang, Y. Z. Li, S. T. Ning, J. C. Chen, and Y. W. Liu. 2012. Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. International Journal of Molecular Medicine 30 (5):1021–1028. doi: 10.3892/ijmm.2012.1096.
  • Chen, Y. Q., Q. M. Xu, X. R. Li, S. L. Yang, and H. X. Zhu-Ge. 2012. In vitro evaluation of schistosomicidal potential of curcumin against Schistosoma japonicum. Journal of Asian Natural Products Research 14:1064–1072.
  • Chen, Z., J. Xue, T. Shen, G. Ba, D. Yu, and Q. Fu. 2016. Curcumin alleviates glucocorticoid‐induced osteoporosis by protecting osteoblasts from apoptosis in vivo and in vitro. Clinical and Experimental Pharmacology and Physiology 43 (2):268–276. doi: 10.1111/1440-1681.12513.
  • Chen, Z., J. Xue, T. Shen, S. Mu, and Q. Fu. 2016. Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. International Journal of Molecular Medicine 37 (2):329–338. doi: 10.3892/ijmm.2015.2432.
  • Cheng, A. L., C. H. Hsu, J. K. Lin, M. M. Hsu, Y. F. Ho, T. S. Shen, J. Y. Ko, J. T. Lin, B. R. Lin, W. Ming-Shiang, et al. 2001. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research 21 (4B):2895–2900.,
  • Cheng, C., J. T. Jiao, Y. Qian, X. Y. Guo, J. Huang, M. C. Dai, L. Zhang, X. P. Ding, D. Zong, and J. F. Shao. 2016. Curcumin induces G2/M arrest and triggers apoptosis via FoxO1 signaling in U87 human glioma cells. Molecular Medicine Reports 13 (5):3763–3770. doi: 10.3892/mmr.2016.5037.
  • Chin, K. Y. 2016. The spice for joint inflammation: Anti-inflammatory role of curcumin in treating osteoarthritis. Drug Design, Development and Therapy 10:3029–3042. doi: 10.2147/DDDT.S117432.
  • Chinembiri, T. N., L. H. Du Plessis, M. Gerber, J. H. Hamman, and J. Du Plessis. 2014. Review of natural compounds for potential skin cancer treatment. Molecules 19 (8):11679–11721. doi: 10.3390/molecules190811679.
  • Choi, G. Y., H. B. Kim, E. S. Hwang, S. Lee, M. J. Kim, J. Y. Choi, S. O. Lee, S. S. Kim, and J. H. Park. 2017. Curcumin alters neural plasticity and viability of intact hippocampal circuits and attenuates behavioral despair and COX-2 expression in chronically stressed rats. Mediators of Inflammation 2017:1. doi: 10.1155/2017/6280925.
  • Chong, L., W. Zhang, Y. Nie, G. Yu, L. Liu, L. Lin, S. Wen, L. Zhu, and C. Li. 2014. Protective effect of curcumin on acute airway inflammation of allergic asthma in mice through Notch1-GATA3 signaling pathway. Inflammation 37 (5):1476–1485. doi: 10.1007/s10753-014-9873-6.
  • Chongtham, A., and N. Agrawal. 2016. Curcumin modulates cell death and is protective in Huntington’s disease model. Scientific Reports 6:18736. doi:10.1038/srep18736.
  • Choudhary, K. M., A. Mishra, V. V. Poroikov, and R. K. Goel. 2013. Ameliorative effect of curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. European Journal of Pharmacology 704 (1–3):33–40. doi: 10.1016/j.ejphar.2013.02.012.
  • Chougala, M. B., J. J. Bhaskar, M. Rajan, and P. V. Salimath. 2012. Effect of curcumin and quercetin on lysosomal enzyme activities in streptozotocin-induced diabetic rats. Clinical Nutrition 31 (5):749–755. doi: 10.1016/j.clnu.2012.02.003.
  • Chueh, S. C., M. K. Lai, I. S. Liu, F. C. Teng, and J. Chen. 2003. Curcumin enhances the immunosuppressive activity of cyclosporine in rat cardiac allografts and in mixed lymphocyte reactions. Transplantation Proceedings 35 (4):1603–1605.
  • Chuengsamarn, S., S. Rattanamongkolgul, B. Phonrat, R. Tungtrongchitr, and S. Jirawatnotai. 2014. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: A randomized controlled trial. The Journal of Nutritional Biochemistry 25 (2):144–150. doi: 10.1016/j.jnutbio.2013.09.013.
  • Chuengsamarn, S., S. Rattanamongkolgul, R. Luechapudiporn, C. Phisalaphong, and S. Jirawatnotai. 2012. Curcumin extract for prevention of type 2 diabetes. Diabetes Care 35 (11):2121–2127.
  • Chung, S. H., S. H. Choi, J. A. Choi, R. S. Chuck, and C. K. Joo. 2012. Curcumin suppresses ovalbumin-induced allergic conjunctivitis. Molecular Vision 18:1966–1972.
  • Cole, G. M., B. Teter, and S. A. Frautschy. 2007. Neuroprotective effects of curcumin. Advances in Experimental Medicine and Biology 595:197–212.
  • Colpitts, C. C., L. M. Schang, H. Rachmawati, A. Frentzen, S. Pfaender, P. Behrendt, R. J. Brown, D. Bankwitz, J. Steinmann, and M. Ott. 2014. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut 63:1137–1149.
  • Corrêa, M., P. Pires, F. Ribeiro, S. Pimentel, R. Casarin, F. Cirano, H. Tenenbaum, and M. Casati. 2017. Systemic treatment with resveratrol and/or curcumin reduces the progression of experimental periodontitis in rats. Journal of Periodontal Research 52 (2):201–209.
  • Cosentino, V., A. Fratter, and M. Cosentino. 2016. Anti-inflammatory effects exerted by Killox®, an innovative formulation of food supplement with curcumin, in urology. European Review for Medical and Pharmacological Sciences 20:1390–1398.
  • Cruz-Correa, M., D. A. Shoskes, P. Sanchez, R. Zhao, L. M. Hylind, S. D. Wexner, and F. M. Giardiello. 2006. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clinical Gastroenterology and Hepatology 4 (8):1035–1038.
  • Cui, L., J. Miao, and L. Cui. 2007. Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: Inhibition of histone acetylation and generation of reactive oxygen species. Antimicrobial Agents and Chemotherapy 51 (2):488–494. doi: 10.1128/AAC.01238-06.
  • Cui, Q., X. Li, and H. Zhu. 2016. Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway. Molecular Medicine Reports 13 (2):1381–1388. doi: 10.3892/mmr.2015.4657.
  • Cui, Y., M. Zhang, F. Zeng, H. Jin, Q. Xu, and Y. Huang. 2016. Dual-targeting magnetic PLGA nanoparticles for codelivery of paclitaxel and curcumin for brain tumor therapy. ACS Applied Materials & Interfaces 8:32159–32169.
  • Cummings, C. J., Y. Sun, P. Opal, B. Antalffy, R. Mestril, H. T. Orr, W. H. Dillmann, and H. Y. Zoghbi. 2001. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Human Molecular Genetics 10 (14):1511–1518. doi: 10.1093/hmg/10.14.1511.
  • Czekaj, R., J. Majka, A. Ptak-Belowska, A. Szlachcic, A. Targosz, K. Magierowska, M. Strzalka, M. Magierowski, and T. Brzozowski. 2016. Role of curcumin in protection of gastric mucosa against stress-induced gastric mucosal damage. Involvement of hypoacidity, vasoactive mediators and sensory neuropeptides. Journal of Physiology and Pharmacology 67:261–275.
  • da Silva, D. L., T. F. F. Magalhães, J. R. A. dos Santos, T. P. de Paula, L. V. Modolo, A. de Fátima, C. V. Buzanello Martins, D. A. Santos, and M. A. de Resende-Stoianoff. 2016. Curcumin enhances the activity of fluconazole against Cryptococcus gattii‐induced cryptococcosis infection in mice. Journal of Applied Microbiology 120 (1):41–48.
  • Dai, P., Y. Mao, X. Sun, X. Li, I. Muhammad, W. Gu, D. Zhang, Y. Zhou, J. Ma, Z. Ni, and S. Huang. 2017. Attenuation of oxidative stress-induced osteoblast apoptosis by curcumin is associated with preservation of mitochondrial functions and increased Akt-GSK3β signaling. Cellular Physiology and Biochemistry 41 (2):661–677. doi: 10.1159/000457945.
  • Daniel, B. S., and R. Wittal. 2015. Vitiligo treatment update. The Australasian Journal of Dermatology 56 (2):85–92.
  • Dao, T. T., P. H. Nguyen, H. K. Won, E. H. Kim, J. Park, B. Y. Won, and W. K. Oh. 2012. Curcuminoids from Curcuma longa and their inhibitory activities on influenza a neuraminidases. Food Chemistry 134 (1):21–28.
  • Darvesh, A. S., B. B. Aggarwal, and A. Bishayee. 2012. Curcumin and liver cancer: A review. Current Pharmaceutical Biotechnology 13:218–228.
  • Dasiram, J. D., R. Ganesan, J. Kannan, V. Kotteeswaran, and N. Sivalingam. 2017. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human Colon adenocarcinoma cells. Biomedicine & Pharmacotherapy 86:373–380. doi: 10.1016/j.biopha.2016.12.034.
  • Dcodhar, S., R. Sethi, and R. Srimal. 1980. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian Journal of Medical Research 71:632–634.
  • de Melo, I. S. V., A. F. Dos Santos, and N. B. Bueno. 2018. Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: Systematic review and meta-analysis of randomized controlled trials. Pharmacological Research 128:137–144.
  • De Paz-Campos, M. A., M. I. Ortiz, A. E. C. Piña, L. Zazueta-Beltrán, and G. Castañeda-Hernández. 2014. Synergistic effect of the interaction between curcumin and diclofenac on the formalin test in rats. Phytomedicine 21 (12):1543–1548.
  • De, R., P. Kundu, S. Swarnakar, T. Ramamurthy, A. Chowdhury, G. B. Nair, and A. K. Mukhopadhyay. 2009. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrobial Agents and Chemotherapy 53 (4):1592–1597. doi: 10.1128/AAC.01242-08.
  • Demiray, M., H. Sahinbas, S. Atahan, H. Demiray, D. Selcuk, I. Yildirim, and A. Atayoglu. 2016. Successful treatment of c-kit-positive metastatic Adenoid Cystic Carcinoma (ACC) with a combination of curcumin plus imatinib: A case report. Complementary Therapies in Medicine 27:108–113.
  • Derosa, G., P. Maffioli, L. E. Simental-Mendía, S. Bo, and A. Sahebkar. 2016. Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research 111:394–404. doi: 10.1016/j.phrs.2016.07.004.
  • Dhanasekaran, S., B. K. Biswal, V. N. Sumantran, and R. S. Verma. 2013. Augmented sensitivity to methotrexate by curcumin induced overexpression of folate receptor in KG-1 cells. Biochimie 95 (8):1567–1573.
  • Dhillon, N., B. B. Aggarwal, R. A. Newman, R. A. Wolff, A. B. Kunnumakkara, J. L. Abbruzzese, C. S. Ng, V. Badmaev, and R. Kurzrock. 2008. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clinical Cancer Research 14 (14):4491–4499.
  • Ding, L., J. Li, B. Song, X. Xiao, B. Zhang, M. Qi, W. Huang, L. Yang, and Z. Wang. 2016. Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway. Toxicology and Applied Pharmacology 304:99–109. doi: 10.1016/j.taap.2016.05.011.
  • Divya, C. S., and M. R. Pillai. 2006. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP‐1 translocation, and modulation of apoptosis. Molecular Carcinogenesis 45 (5):320–332.
  • Dong, H. J., C. Z. Shang, D. W. Peng, J. Xu, P. X. Xu, L. Zhan, and P. Wang. 2014. Curcumin attenuates ischemia-like injury induced IL-1β elevation in brain microvascular endothelial cells via inhibiting MAPK pathways and nuclear factor-κB activation. Neurological Sciences 35 (9):1387–1392. doi: 10.1007/s10072-014-1718-4.
  • Dovigo, L. N., J. C. Carmello, C. A. de Souza Costa, C. E. Vergani, I. L. Brunetti, V. S. Bagnato, and A. C. Pavarina. 2013. Curcumin-mediated photodynamic inactivation of Candida albicans in a murine model of oral candidiasis. Medical Mycology 51 (3):243–251. doi: 10.3109/13693786.2012.714081.
  • Drion, C. M., L. E. Borm, L. Kooijman, E. Aronica, W. J. Wadman, A. F. Hartog, E. A. Vliet, and J. A. Gorter. 2016. Effects of rapamycin and curcumin treatment on the development of epilepsy after electrically induced status epilepticus in rats. Epilepsia 57 (5):688–697. doi: 10.1111/epi.13345.
  • Du, P., H. Tang, X. Li, H. Lin, W. Peng, Y. Ma, W. Fan, and X. Wang. 2012. Anticonvulsive and antioxidant effects of curcumin on pilocarpine-induced seizures in rats. Chinese Medical Journal 125 (11):1975–1979.
  • Durgaprasad, S., C. G. Pai, and J. F. Alvres. 2005. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian Journal of Medical Research 122:315–318.
  • Dutta, K., D. Ghosh, and A. Basu. 2009. Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system. Journal of Neuroimmune Pharmacology 4 (3):328–337.
  • El Swefy, S., R. A. Hasan, A. Ibrahim, and M. F. Mahmoud. 2016. Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: Role of CB1 receptors. Naunyn-Schmiedeberg’s Archives of Pharmacology 389 (1):103–116.
  • Elamin, M. H., Z. Shinwari, S. F. Hendrayani, H. Al-Hindi, E. Al-Shail, Y. Khafaga, A. Al-Kofide, and A. Aboussekhra. 2010. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Molecular Carcinogenesis 49:302–314.
  • El-Desoky, G., A. Abdel-Ghaffar, Z. Al-Othman, M. Habila, Y. Al-Sheikh, H. Ghneim, J. Giesy, and M. Aboul-Soud. 2017. Curcumin protects against tartrazine-mediated oxidative stress and hepatotoxicity in male rats. European Review for Medical and Pharmacological Sciences 21:635–645.
  • El-Houseini, M. E., I. A. El-Agoza, M. M. Sakr, and G. M. El-Malky. 2017. Novel protective role of curcumin and taurine combination against experimental hepatocarcinogenesis. Experimental and Therapeutic Medicine 13:29–36.
  • Epelbaum, R., M. Schaffer, B. Vizel, V. Badmaev, and G. Bar-Sela. 2010. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutrition and Cancer 62 (8):1137–1141.
  • Esmaily, H., A. Sahebkar, M. Iranshahi, S. Ganjali, A. Mohammadi, G. Ferns, and M. Ghayour-Mobarhan. 2015. An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial. Chinese Journal of Integrative Medicine 21 (5):332–338. doi: 10.1007/s11655-015-2160-z.
  • Fan, J., Y. Zeng, J. Wu, Z. Li, Y. Li, R. Zheng, G. Weng, and K. Guo. 2014. Synergistic killing effect of arsenic trioxide combined with curcumin on KG1a cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 22 (5):1267–1272.
  • Fanaei, H., S. Khayat, A. Kasaeian, and M. Javadimehr. 2016. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial. Neuropeptides 56:25–31.
  • Farooqui, A. A. 2013. Beneficial effects of curcumin on neurological disorders. In Phytochemicals, Signal transduction, and neurological disorders, 151–197. Boston, MA: Springer.
  • Farzaei, M. H., F. Farzaei, M. Gooshe, Z. Abbasabadi, N. Rezaei, and A. H. Abdolghaffari. 2015. Potentially effective natural drugs in treatment for the most common rheumatic disorder: Osteoarthritis. Rheumatology International 35 (5):799–814. doi: 10.1007/s00296-014-3175-z.
  • Farzaei, M. H., R. Bahramsoltani, A. H. Abdolghaffari, H. R. Sodagari, S. A. Esfahani, and N. Rezaei. 2016a. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 10:745–758. doi: 10.1586/17474124.2016.1145546.
  • Farzaei, M. H., R. Bahramsoltani, M. Abdollahi, and R. Rahimi. 2016b. The role of visceral hypersensitivity in irritable bowel syndrome: Pharmacological targets and novel treatments. Journal of Neurogastroenterology and Motility 22 (4):558–574. doi: 10.5056/jnm16001.
  • Farzaei, M. H., R. Bahramsoltani, R. Rahimi, F. Abbasabadi, and M. Abdollahi. 2016c. A systematic review of plant-derived natural compounds for anxiety disorders. Current Topics in Medicinal Chemistry 16 (17):1924–1942. doi: 10.2174/1568026616666160204121039.
  • Fassbender, K., M. Simons, C. Bergmann, M. Stroick, D. Lutjohann, P. Keller, H. Runz, S. Kuhl, T. Bertsch, K. von Bergmann, et al. 2001. Simvastatin strongly reduces levels of Alzheimer’s disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 98 (10):5856–5861. doi: 10.1073/pnas.081620098.
  • Feng, W., H. Wang, P. Zhang, C. Gao, J. Tao, Z. Ge, D. Zhu, and Y. Bi. 2017. Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats. Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (7):1801–1812. doi: 10.1016/j.bbagen.2017.03.017.
  • Fibach, E., and E. Rachmilewitz. 2008. The role of oxidative stress in hemolytic anemia. Current Molecular Medicine 8 (7):609–619.
  • Franco-Robles, E., A. Campos-Cervantes, B. O. Murillo-Ortiz, J. Segovia, S. LópezBriones, P. Vergara, V. Pérez-Vázquez, M. S. Solís-Ortiz, and J. Ramírez-Emiliano. 2014. Effects of curcumin on brain-derived neurotrophic factor levels and oxidative damage in obesity and diabetes. Applied Physiology, Nutrition, and Metabolism 39 (2):211–218. doi: 10.1139/apnm-2013-0133.
  • Gallardo, M., and G. M. Calaf. 2016. Curcumin inhibits invasive capabilities through epithelial mesenchymal transition in breast cancer cell lines. International Journal of Oncology 49 (3):1019–1027. doi: 10.3892/ijo.2016.3598.
  • Gan, L., C. Li, J. Wang, and X. Guo. 2016. Curcumin modulates the effect of histone modification on the expression of chemokines by type II alveolar epithelial cells in a rat COPD model. International Journal of Chronic Obstructive Pulmonary Disease 11:2765–2773. doi: 10.2147/COPD.S113978.
  • Ganjali, S., A. Sahebkar, E. Mahdipour, K. Jamialahmadi, S. Torabi, S. Akhlaghi, G. Ferns, S. M. R. Parizadeh, and M. Ghayour-Mobarhan. 2014. Investigation of the effects of curcumin on serum cytokines in obese individuals: A randomized controlled trial. The Scientific World Journal 2014:1. doi: 10.1155/2014/898361.
  • Ganjali, S., C. N. Blesso, M. Banach, M. Pirro, M. Majeed, and A. Sahebkar. 2017. Effects of curcumin on HDL functionality. Pharmacological Research 119:208–218. doi: 10.1016/j.phrs.2017.02.008.
  • Gao, J., H. Zhou, T. Lei, L. Zhou, W. Li, X. Li, and B. Yang. 2011. Curcumin inhibits renal cyst formation and enlargement in vitro by regulating intracellular signaling pathways. European Journal of Pharmacology 654 (1):92–99.
  • Garufi, A., V. D'Orazi, A. Crispini, and G. D'Orazi. 2015. Zn (II)-curc targets p53 in thyroid cancer cells. International Journal of Oncology 47 (4):1241–1248. doi: 10.3892/ijo.2015.3125.
  • Geng, H. H., R. Li, Y. M. Su, J. Xiao, M. Pan, X. X. Cai, and X. P. Ji. 2016. Curcumin protects cardiac myocyte against hypoxia-induced apoptosis through upregulating miR-7a/b expression. Biomedicine & Pharmacotherapy 81:258–264. doi: 10.1016/j.biopha.2016.04.020.
  • Ghaemi-Jandabi, M., H. Abdollahi, H. Azizi, M. Sadeghizadeh, and S. Semnanian. 2015. Dendrosomal curcumin nanoformulation attenuates naloxone precipitated morphine withdrawal signs in rats. Journal of Addiction Research and Therapy 6 (211). doi:10.4172/21556105.1000211.
  • Ghalaut, V. S., L. Sangwan, K. Dahiya, P. Ghalaut, R. Dhankhar, and R. Saharan. 2012. Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia. Journal of Oncology Pharmacy Practice 18 (2):186–190. doi: 10.1177/1078155211416530.
  • Ghorbani, Z., M. Hajizadeh, and A. Hekmatdoost. 2016. Dietary supplementation in patients with alcoholic liver disease: A review on current evidence. Hepatobiliary & Pancreatic Diseases International 15:348–360. doi: 10.1016/S1499-3872(16)60096-6.
  • Ghosh, S., S. Banerjee, and P. C. Sil. 2015. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food and Chemical Toxicology 83:111–124.
  • Goel, A., A. B. Kunnumakkara, and B. B. Aggarwal. 2008. Curcumin as “Curecumin”: From kitchen to clinic. Biochemical Pharmacology 75 (4):787–809.
  • Gokce, E. C., R. Kahveci, A. Gokce, M. F. Sargon, U. Kisa, N. Aksoy, B. Cemil, and B. Erdogan. 2016. Curcumin attenuates inflammation, oxidative stress, and ultrastructural damage induced by spinal cord ischemia-reperfusion injury in rats. Journal of Stroke and Cerebrovascular Diseases 25 (5):1196–1207. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.008.
  • Gomez-Bougie, P., M. Halliez, S. Maïga, C. Godon, C. Kervoëlen, C. Pellat-Deceunynck, P. Moreau, and M. Amiot. 2015. Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups. Cancer Biology & Therapy 16:60–65. doi: 10.4161/15384047.2014.986997.
  • Gopal, P. K., M. Paul, and S. Paul. 2014. Curcumin induces caspase mediated apoptosis in JURKAT cells by disrupting the redox balance. Asian Pacific Journal of Cancer Prevention 15 (1):93–100. doi: 10.7314/APJCP.2014.15.1.93.
  • Gottumukkala, S. N., S. Koneru, S. Mannem, and N. Mandalapu. 2013. Effectiveness of Sub gingival irrigation of an indigenous 1% curcumin solution on clinical and microbiological parameters in chronic periodontitis patients: A pilot randomized clinical trial. Contemporary Clinical Dentistry 4 (2):186–191.
  • Gottumukkala, S. N., S. Sudarshan, and S. R. Mantena. 2014. Comparative evaluation of the efficacy of two controlled release devices: Chlorhexidine chips and indigenous curcumin based collagen as local drug delivery systems. Contemporary Clinical Dentistry 5 (2):175–181. doi: 10.4103/0976-237X.132310.
  • Griffin, W. S., J. G. Sheng, M. C. Royston, S. M. Gentleman, J. E. McKenzie, D. I. Graham, G. W. Roberts, and R. E. Mrak. 2006. Glial-neuronal interactions in Alzheimer’s disease: The potential role of a ‘cytokine cycle’ in disease progression. Brain Pathology 8 (1):65–72. doi: 10.1111/j.1750-3639.1998.tb00136.x.
  • Gugulothu, D., A. Kulkarni, V. Patravale, and P. Dandekar. 2014. pH‐Sensitive nanoparticles of curcumin–celecoxib combination: Evaluating drug synergy in ulcerative colitis model. Journal of Pharmaceutical Sciences 103 (2):687–696.
  • Guo, C., J. Ma, Q. Zhong, M. Zhao, T. Hu, T. Chen, L. Qiu, and L. Wen. 2017. Curcumin improves alcoholic fatty liver by inhibiting fatty acid biosynthesis. Toxicology and Applied Pharmacology 328:1–9. doi: 10.1016/j.taap.2017.05.001.
  • Guo, J., W. Li, H. Shi, X. Xie, L. Li, H. Tang, M. Wu, Y. Kong, L. Yang, J. Gao, et al. 2013a. Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a. Molecular and Cellular Biochemistry 382 (1-2):103–111.,
  • Guo, L. D., Y. Q. Shen, X. H. Zhao, L. J. Guo, Z. J. Yu, D. Wang, L. M. Liu, and J. Z. Liu. 2015. Curcumin combined with oxaliplatin effectively suppress colorectal carcinoma in vivo through inducing apoptosis. Phytotherapy Research 29 (3):357–365.
  • Guo, X., S. Yin, Y. Dong, L. Fan, M. Ye, J. Lu, and H. Hu. 2013b. Enhanced apoptotic effects by the combination of curcumin and methylseleninic acid: Potential role of Mcl‐1 and FAK. Molecular Carcinogenesis 52 (11):879–889.
  • Guo, Y., Q. Shan, Y. Gong, J. Lin, F. Shi, R. Shi, and X. Yang. 2014. Curcumin induces apoptosis via simultaneously targeting AKT/mTOR and RAF/MEK/ERK survival signaling pathways in human leukemia THP-1 cells. Pharmazie 69 (3):229–233.
  • Gupta, S. C., G. Kismali, and B. B. Aggarwal. 2013a. Curcumin, a component of turmeric: From farm to pharmacy. BioFactors (Oxford, England) 39 (1):2–13.
  • Gupta, S. C., S. Patchva, and B. B. Aggarwal. 2013b. Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS Journal 15 (1):195–218.
  • Gupta, S. C., S. Prasad, J. H. Kim, S. Patchva, L. J. Webb, I. K. Priyadarsini, and B. B. Aggarwal. 2011. Multitargeting by curcumin as revealed by molecular interaction studies. Natural Product Reports 28 (12):1937–1955. doi: 10.1039/c1np00051a.
  • Gupta, Y. K., S. Briyal, and M. Sharma. 2009. Protective effect of curcumin against kainic acid induced seizures and oxidative stress in rats. Indian Journal of Physiology and Pharmacology 53:39–46.
  • Haider, S., F. Naqvi, Z. Batool, S. Tabassum, S. Sadir, L. Liaquat, F. Naqvi, N. A. Zuberi, H. Shakeel, and T. Perveen. 2015. Pretreatment with curcumin attenuates anxiety while strengthens memory performance after one short stress experience in male rats. Brain Research Bulletin 115:1–8. doi: 10.1016/j.brainresbull.2015.04.001.
  • Hallman, K., K. Aleck, B. Dwyer, V. Lloyd, M. Quigley, N. Sitto, A. E. Siebert, and S. Dinda. 2017. The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells. Breast Cancer: Targets and Therapy 9:153–161. doi: 10.2147/BCTT.S125783.
  • Hamaguchi, T., K. Ono, A. Murase, and M. Yamada. 2009. Phenolic compounds prevent Alzheimer’s pathology through different effects on the amyloid-β aggregation pathway. The American Journal of Pathology 175 (6):2557–2565. doi: 10.2353/ajpath.2009.090417.
  • Hamaguchi, T., K. Ono, and M. Yamada. 2010. Review: Curcumin and Alzheimer’s disease. CNS Neuroscience & Therapeutics 16 (5):285–297.
  • Hanai, H., and K. Sugimoto. 2009. Curcumin has bright prospects for the treatment of inflammatory bowel disease. Current Pharmaceutical Design 15 (18):2087–2094.
  • Hanai, H., T. Iida, K. Takeuchi, F. Watanabe, Y. Maruyama, A. Andoh, T. Tsujikawa, Y. Fujiyama, K. Mitsuyama, M. Sata, et al. 2006. Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial. Clinical Gastroenterology and Hepatology 4 (12):1502–1506., doi: 10.1016/j.cgh.2006.08.008.
  • Hasan, S., J. M. Zingg, P. Kwan, T. Noble, D. Smith, and M. Meydani. 2014. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice. Atherosclerosis 232 (1):40–51. doi: 10.1016/j.atherosclerosis.2013.10.016.
  • Hassaninasab, A., Y. Hashimoto, K. Tomita-Yokotani, and M. Kobayashi. 2011. Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proceedings of the National Academy of Sciences 108 (16):6615–6620.
  • He, M., Y. Li, L. Zhang, L. Li, Y. Shen, L. Lin, W. Zheng, L. Chen, X. Bian, H.-K. Ng, and L. Tang. 2014. Curcumin suppresses cell proliferation through inhibition of the Wnt/β-catenin signaling pathway in medulloblastoma. Oncology Reports 32 (1):173–180. doi: 10.3892/or.2014.3206.
  • He, P., R. Zhou, G. Hu, Z. Liu, Y. Jin, G. Yang, M. Li, and Q. Lin. 2015a. Curcumin-induced histone acetylation inhibition improves stress-induced gastric ulcer disease in rats. Molecular Medicine Reports 11 (3):1911–1916. doi: 10.3892/mmr.2014.2958.
  • He, X. J., K. Uchida, C. Megumi, N. Tsuge, and H. Nakayama. 2015b. Dietary curcumin supplementation attenuates 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) neurotoxicity in C57BL mice. Journal of Toxicologic Pathology 28 (4):197–206. doi: 10.1293/tox.2015-0020.
  • He, Y., Y. Yue, X. Zheng, K. Zhang, S. Chen, and Z. Du. 2015c. Curcumin, inflammation, and chronic diseases: How are they linked? Molecules 20 (5):9183–9213. doi: 10.3390/molecules20059183.
  • Heng, M., M. Song, J. Harker, and M. Heng. 2000. Drug‐induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. British Journal of Dermatology 143 (5):937–949.
  • Hewlings, S. J., and D. S. Kalman. 2017. Curcumin: A review of its’ effects on human health. Foods 6 (10):92. doi: 10.3390/foods6100092.
  • Hickey, M. A., C. Zhu, V. Medvedeva, R. P. Lerner, S. Patassini, N. R. Franich, P. Maiti, S. A. Frautschy, S. Zeitlin, M. S. Levine, and M.-F. Chesselet. 2012. Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington’s disease. Molecular Neurodegeneration 7 (1):12. doi: 10.1186/1750-1326-7-12.
  • Hoehle, S. I., E. Pfeiffer, A. M. Sólyom, and M. Metzler. 2006. Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. Journal of Agricultural and Food Chemistry 54 (3):756–764.
  • Holt, P. R., S. Katz, and R. Kirshoff. 2005. Curcumin therapy in inflammatory bowel disease: A pilot study. Digestive Diseases and Sciences 50 (11):2191–2193. doi: 10.1007/s10620-005-3032-8.
  • Hossain, M. M., N. L. Banik, and S. K. Ray. 2012. Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells. Neurochemistry International 61 (7):1102–1113.
  • Hsu, C.H., and A.L. Cheng. 2007. Clinical studies with curcumin. In The molecular targets and therapeutic uses of curcumin in health and disease, edited by B. B. Aggarwal, Y.-J. Surh, and S. Shishodia, 471–480. Boston, MA: Springer.
  • Hu, B., D. Sun, C. Sun, Y.-F. Sun, H.-X. Sun, Q.-F. Zhu, X.-R. Yang, Y.-B. Gao, W.-G. Tang, J. Fan, et al. 2015a. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma. Biochemical and Biophysical Research Communications 468 (4):525–532.,
  • Hu, C. W., Y. Sheng, Q. Zhang, H. B. Liu, X. Xie, W. C. Ma, R. Huo, and D. L. Dong. 2012. Curcumin inhibits hERG potassium channels in vitro. Toxicology Letters 208 (2):192–196. doi: 10.1016/j.toxlet.2011.11.005.
  • Hu, X., F. Huang, M. Szymusiak, Y. Liu, and Z. J. Wang. 2015b. Curcumin attenuates opioid tolerance and dependence by inhibiting Ca2+/calmodulin-dependent protein kinase II α activity. Journal of Pharmacology and Experimental Therapeutics 352 (3):420–428. doi: 10.1124/jpet.114.219303.
  • Hu, Y., L. Mou, F. Yang, H. Tu, and W. Lin. 2016. Curcumin attenuates cyclosporine a‑induced renal fibrosis by inhibiting hypermethylation of the klotho promoter. Molecular Medicine Reports 14 (4):3229–3236. doi: 10.3892/mmr.2016.5601.
  • Huang, G., Z. Xu, Y. Huang, X. Duan, W. Gong, Y. Zhang, J. Fan, and F. He. 2013. Curcumin protects against collagen-induced arthritis via suppression of BAFF production. Journal of Clinical Immunology 33 (3):550–557. doi: 10.1007/s10875-012-9839-0.
  • Huang, H. C., D. Tang, K. Xu, and Z. F. Jiang. 2014. Curcumin attenuates amyloid-beta-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3beta signaling pathway. Journal of Receptors and Signal Transduction 34 (1):26–37. Res doi: 10.3109/10799893.2013.848891.
  • Huang, H., X. Chen, D. Li, Y. He, Y. Li, Z. Du, K. Zhang, R. DiPaola, S. Goodin, and X. Zheng. 2015a. Combination of α-tomatine and curcumin inhibits growth and induces apoptosis in human prostate cancer cells. PLoS One 10 (12):e0144293.
  • Huang, L., J. Zhang, T. Song, L. Yuan, J. Zhou, H. Yin, T. He, W. Gao, Y. Sun, X. Hu, and H. Huang. 2016a. Antifungal curcumin promotes chitin accumulation associated with decreased virulence of Sporothrix schenckii. International Immunopharmacology 34:263–270. doi: 10.1016/j.intimp.2016.03.010.
  • Huang, R., Y. Liu, Y. Xiong, H. Wu, G. Wang, Z. Sun, J. Chen, X. Yan, Z. Pan, and J. Xia. 2016b. Curcumin protects against liver fibrosis by attenuating infiltration of Gr1hi Monocytes through inhibition of monocyte chemoattractant protein-1. Discovery Medicine 21:447–457.
  • Huang, X., C. S. Atwood, R. D. Moir, M. A. Hartshorn, R. E. Tanzi, and A. I. Bush. 2004. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Abeta peptides. JBIC Journal of Biological Inorganic Chemistry 9 (8):954–960. doi: 10.1007/s00775-004-0602-8.
  • Huang, Y. F., D. J. Zhu, X. W. Chen, Q. K. Chen, Z. T. Luo, C. C. Liu, G. X. Wang, W. J. Zhang, and N. Z. Liao. 2017. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway. Oncotarget 8:40264–40275.
  • Huang, Z., B. Ye, Z. Dai, X. Wu, Z. Lu, P. Shan, and W. Huang. 2015b. Curcumin inhibits autophagy and apoptosis in hypoxia/reoxygenation-induced myocytes. Molecular Medicine Reports 11 (6):4678–4684. doi: 10.3892/mmr.2015.3322.
  • Imbaby, S., M. Ewais, S. Essawy, and N. Farag. 2014. Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats. Human & Experimental Toxicology 33:800–813.
  • Imran, M., F. Saeed, M. Nadeem, M. U. Arshad, A. Ullah, and H. A. R. Suleria. 2016. Cucurmin; anticancer and antitumor perspectives: A comprehensive review. Critical Reviews in Food Science and Nutrition 22:1–23.
  • Ireson, C. R., D. J. Jones, S. Orr, M. W. Coughtrie, D. J. Boocock, M. L. Williams, P. B. Farmer, W. P. Steward, and A. J. Gescher. 2002. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiology and Prevention Biomarkers 11:105–111.
  • Jain, A., S. Doppalapudi, A. J. Domb, and W. Khan. 2016. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis. Journal of Controlled Release 243:132–145.
  • Jangra, A., M. Kwatra, T. Singh, R. Pant, P. Kushwah, Y. Sharma, B. Saroha, A. K. Datusalia, and B. K. Bezbaruah. 2016. Piperine augments the protective effect of curcumin against lipopolysaccharide-induced neurobehavioral and neurochemical deficits in mice. Inflammation 39:1025–1038.
  • Jayanarayanan, S., S. Smijin, K. Peeyush, T. Anju, and C. Paulose. 2013. NMDA and AMPA receptor mediated excitotoxicity in cerebral cortex of streptozotocin induced diabetic rat: Ameliorating effects of curcumin. Chemico-Biological Interactions 201 (1–3):39–48. doi: 10.1016/j.cbi.2012.11.024.
  • Jena, S., C. Anand, G. B. N. Chainy, and J. Dandapat. 2012. Induction of oxidative stress and inhibition of superoxide dismutase expression in rat cerebral cortex and cerebellum by PTU-induced hypothyroidism and its reversal by curcumin. Neurological Sciences 33 (4):869–873. doi: 10.1007/s10072-011-0853-4.
  • Jena, S., J. Dandapat, and G. B. N. Chainy. 2013. Curcumin differentially regulates the expression of superoxide dismutase in cerebral cortex and cerebellum of l-thyroxine (T4)-induced hyperthyroid rat brain. Neurological Sciences 34 (4):505–510. doi: 10.1007/s10072-012-1084-z.
  • Jeong, E. H., B. Vaidya, S. Y. Cho, M. A. Park, K. Kaewintajuk, S. R. Kim, M. J. Oh, J. S. Choi, J. Kwon, and D. Kim. 2015. Identification of regulators of the early stage of viral hemorrhagic septicemia virus infection during curcumin treatment. Fish & Shellfish Immunology 45:184–193.
  • Jha, A., M. Nikbakht, G. Parashar, A. Shrivastava, N. Capalash, and J. Kaur. 2010. Reversal of hypermethylation and reactivation of the RAR [Beta] 2 gene by natural compounds in cervical cancer cell lines. Folia Biologica 56:195–200.
  • Jia, Y. L., J. Li, Z. H. Qin, and Z. Q. Liang. 2009. Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. Journal of Asian Natural Products Research 11 (11):918–928. doi: 10.1080/10286020903264077.
  • Jiang, H., D. Geng, H. Liu, Z. Li, and J. Cao. 2016. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors. Drug Delivery 23 (9):3665–3673.
  • Jiang, J., W. Wang, Y. J. Sun, M. Hu, F. Li, and D. Y. Zhu. 2007. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. European Journal of Pharmacology 561 (1–3):54–62. doi: 10.1016/j.ejphar.2006.12.028.
  • Jiang, S., J. Han, T. Li, Z. Xin, Z. Ma, W. Di, W. Hu, B. Gong, S. Di, D. Wang, and Y. Yang. 2017. Curcumin as a potential protective compound against cardiac diseases. Pharmacological Research 119:373–383.
  • Jiang, T. F., Y. J. Zhang, H. Y. Zhou, H. M. Wang, L. P. Tian, J. Liu, J. Q. Ding, and S. D. Chen. 2013. Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson’s disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy. Journal of Neuroimmune Pharmacology 8 (1):356–369. doi: 10.1007/s11481-012-9431-7.
  • Jiang, T., X. L. Zhi, Y. H. Zhang, L. F. Pan, and P. Zhou. 2012. Inhibitory effect of curcumin on the Al(III)-induced abeta(4)(2) aggregation and neurotoxicity in vitro. Biochimica et Biophysica Acta 1822 (8):1207–1215. doi: 10.1016/j.bbadis.2012.04.015.
  • Jiao, D., J. Wang, W. Lu, X. Tang, J. Chen, H. Mou, and Q. Y. Chen. 2016. Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer. Molecular Therapy Oncolytics 3:16018. doi:10.1038/mto.2016.18.
  • Jiménez-Osorio, A. S., A. Monroy, and S. Alavez. 2016. Curcumin and insulin resistance-molecular targets and clinical evidences. Biofactors 42 (6):561–580.
  • Jinfeng, L., W. Yunliang, L. Xinshan, W. Yutong, W. Shanshan, X. Peng, Y. Xiaopeng, X. Zhixiu, L. Qingshan, Y. Honglei, et al. 2016. Therapeutic effects of CUR-activated human umbilical cord mesenchymal stem cells on 1-methyl-4-phenylpyridine-induced Parkinson’s disease cell model. BioMed Research International 2016:1–12. doi: 10.1155/2016/9140541.
  • Jordan, B. C., C. D. Mock, R. Thilagavathi, and C. Selvam. 2016. Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment. Life Sciences 152:135–144. doi: 10.1016/j.lfs.2016.03.036.
  • Judaki, A., A. Rahmani, J. Feizi, K. Asadollahi, and M. R. Hafezi Ahmadi. 2017. Curcumin in combination with triple therapy regimes ameliorates oxidative stress and histopathologic changes in chronic gastritis-associated helicobacter pylori infection. Arquivos de Gastroenterologia 54 (3):177–182. doi: 10.1590/s0004-2803.201700000-18.
  • Kamarudin, T. A., F. Othman, E. S. M. Ramli, N. M. Isa, and S. Das. 2012. Protective effect of curcumin on experimentally induced arthritic rats: Detailed histopathological study of the joints and white blood cell count. EXCLI Journal 11:226–236.
  • Kang, D., B. Li, L. Luo, W. Jiang, Q. Lu, M. Rong, and R. Lai. 2016. Curcumin shows excellent therapeutic effect on psoriasis in mouse model. Biochimie 123:73–80. doi: 10.1016/j.biochi.2016.01.013.
  • Kapakos, G., V. Youreva, and A. K. Srivastava. 2012. Cardiovascular protection by curcumin: Molecular aspects. Indian Journal of Biochemistry & Biophysics 49:306–315.
  • Karaman, M., Z. Arıkan Ayyıldız, F. Fırıncı, M. Kiray, A. Bağrıyanık, O. Yilmaz, N. Uzuner, and Ö. Karaman. 2011. Effects of curcumin on lung histopathology and fungal burden in a mouse model of chronic asthma and oropharyngeal candidiasis. Archives of Medical Research 42 (2):79–87. doi: 10.1016/j.arcmed.2011.01.011.
  • Kasi, P. D., R. Tamilselvam, K. Skalicka-Woźniak, S. F. Nabavi, M. Daglia, A. Bishayee, H. Pazoki-Toroudi, and S. M. Nabavi. 2016. Molecular targets of curcumin for cancer therapy: An updated review. Tumor Biology 37 (10):13017–13028. doi: 10.1007/s13277-016-5183-y.
  • Kato, M., S. Nishikawa, A. Ikehata, K. Dochi, T. Tani, T. Takahashi, A. Imaizumi, and T. Tsuda. 2017. Curcumin improves glucose tolerance via stimulation of glucagon‐like peptide‐1 secretion. Molecular Nutrition & Food Research 61. doi:10.1002/mnfr.201600471.
  • Kaur, A., T. Kaur, B. Singh, D. Pathak, H. Singh Buttar, and A. Pal Singh. 2016. Curcumin alleviates ischemia reperfusion-induced acute kidney injury through NMDA receptor antagonism in rats. Renal Failure 38 (9):1462–1467. doi: 10.1080/0886022X.2016.1214892.
  • Kaur, G., and C. Meena. 2012. Amelioration of obesity, glucose intolerance, and oxidative stress in high-fat diet and low-dose streptozotocin-induced diabetic rats by combination consisting of “curcumin with piperine and quercetin. ISRN Pharmacology 2012:1. doi:10.5402/2012/957283.
  • Kaur, H., I. Patro, K. Tikoo, and R. Sandhir. 2015. Curcumin attenuates inflammatory response and cognitive deficits in experimental model of chronic epilepsy. Neurochemistry International 89:40–50. doi: 10.1016/j.neuint.2015.07.009.
  • Kaur, M., A. Singh, B. Kumar, S. K. Singh, A. Bhatia, M. Gulati, T. Prakash, P. Bawa, and A. H. Malik. 2017. Protective effect of co-administration of curcumin and sildenafil in alcohol induced neuropathy in rats. European Journal of Pharmacology 805:58–66.
  • Khajehdehi, P., B. Zanjaninejad, E. Aflaki, M. Nazarinia, F. Azad, L. Malekmakan, and G. R. Dehghanzadeh. 2012. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: A randomized and placebo-controlled study. Journal of Renal Nutrition 22 (1):50–57.
  • Khajehdehi, P., M. Pakfetrat, K. Javidnia, F. Azad, L. Malekmakan, M. H. Nasab, and G. Dehghanzadeh. 2011. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: A randomized, double-blind and placebo-controlled study. Scandinavian Journal of Urology and Nephrology 45 (5):365–370.
  • Khatri, D. K., and A. R. Juvekar. 2016. Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson’s disease. Pharmacology Biochemistry and Behavior 150:39–47. doi: 10.1016/j.pbb.2016.09.002.
  • Khaw, A. K., M. P. Hande, G. Kalthur, and M. P. Hande. 2013. Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells. Journal of Cellular Biochemistry 114 (6):1257–1270. doi: 10.1002/jcb.24466.
  • Kheradpezhouh, E., M. R. Panjehshahin, R. Miri, K. Javidnia, A. Noorafshan, A. Monabati, and A. R. Dehpour. 2010. Curcumin protects rats against acetaminophen-induced hepatorenal damages and shows synergistic activity with N-acetyl cysteine. European Journal of Pharmacology 628 (1–3):274–281.
  • Khonche, A., O. Biglarian, Y. Panahi, G. Valizadegan, S. Soflaei, M. Ghamarchehreh, M. Majeed, and A. Sahebkar. 2016. Adjunctive therapy with curcumin for peptic ulcer: A randomized controlled trial. Drug Research 66:444–448. doi: 10.1055/s-0042-109394.
  • Khoury, T., A. A. Rmeileh, L. Yosha, A. A. Benson, S. Daher, and M. Mizrahi. 2015. Drug induced liver injury: Review with a focus on genetic factors, tissue diagnosis, and treatment options. Journal of Clinical and Translational Hepatology 3:99–108.
  • Kiasalari, Z., M. Roghani, M. Khalili, B. Rahmati, and T. Baluchnejadmojarad. 2013. Antiepileptogenic effect of curcumin on kainate-induced model of temporal lobe epilepsy. Pharmaceutical Biology 51 (12):1572–1578. doi: 10.3109/13880209.2013.803128.
  • Kim, B., H. S. Kim, E. J. Jung, J. Y. Lee, B. K Tsang, J. M. Lim, and Y. S. Song. 2016a. Curcumin induces ER stress‐mediated apoptosis through selective generation of reactive oxygen species in cervical cancer cells. Molecular Carcinogenesis 55 (5):918–928. doi: 10.1002/mc.22332.
  • Kim, C. Y., T. T. Le, C. Chen, J. X. Cheng, and K. H. Kim. 2011. Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion. The Journal of Nutritional Biochemistry 22 (10):910–920. doi: 10.1016/j.jnutbio.2010.08.003.
  • Kim, H., J. Park, K. H. Tak, S. Y. Bu, and E. Kim. 2014. Chemopreventive effects of curcumin on chemically induced mouse skin carcinogenesis in BK5.insulin-like growth factor-1 transgenic mice. In Vitro Cellular & Developmental Biology - Animal 50 (9):883–892. doi: 10.1007/s11626-014-9791-9.
  • Kim, J. H., S. Jin, H. J. Kwon, and B. W. Kim. 2016b. Curcumin blocks naproxen-induced gastric antral ulcerations through inhibition of lipid peroxidation and activation of enzymatic scavengers in rats. Journal of Microbiology and Biotechnology: JMB 26 (8):1392–1397. doi: 10.4014/jmb.1602.02028.
  • Kim, J., S. Park, B. S. Jeon, W. S. Jang, S. J. Lee, Y. Son, K. J. Rhim, S. I. Lee, and S. S. Lee. 2016c. Therapeutic effect of topical application of curcumin during treatment of radiation burns in a mini-pig model. Journal of Veterinary Science 17 (4):435–444. doi: 10.4142/jvs.2016.17.4.435.
  • Kim, K., K. H. Kim, H. Y. Kim, H. K. Cho, N. Sakamoto, and J. Cheong. 2010. Curcumin inhibits hepatitis C virus replication via suppressing the Akt‐SREBP‐1 pathway. FEBS Letters 584 (4):707–712. doi: 10.1016/j.febslet.2009.12.019.
  • Kim, M. K., G. J. Choi, and H. S. Lee. 2003. Fungicidal property of Curcuma longa L. rhizomederived curcumin against phytopathogenic fungi in a greenhouse. Journal of Agricultural and Food Chemistry 51 (6):1578–1581. doi: 10.1021/jf0210369.
  • Kinney, S. R., L. Carlson, J. Ser-Dolansky, C. Thompson, S. Shah, A. Gambrah, W. Xing, S. S. Schneider, and C. B. Mathias. 2015. Curcumin ingestion inhibits mastocytosis and suppresses intestinal anaphylaxis in a murine model of food allergy. PLoS One 10 (7):e0132467. doi: 10.1371/journal.pone.0132467.
  • Klinger, N. V., and S. Mittal. 2016. Therapeutic potential of curcumin for the treatment of brain tumors. Oxidative Medicine and Cellular Longevity 2016:1. doi: 10.1155/2016/9324085.
  • Kloesch, B., T. Becker, E. Dietersdorfer, H. Kiener, and G. Steiner. 2013. Anti-inflammatory and apoptotic effects of the polyphenol curcumin on human fibroblast-like synoviocytes. International Immunopharmacology 15 (2):400–405. doi: 10.1016/j.intimp.2013.01.003.
  • Kocaadam, B., and N. Şanlier. 2017. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Critical Reviews in Food Science and Nutrition 57 (13):2889–2895.
  • Kondo, A., M. Mogi, Y. Koshihara, and A. Togari. 2001. Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochemical Pharmacology 61 (3):319–326. doi: 10.1016/S0006-2952(00)00544-X.
  • Koosirirat, C., S. Linpisarn, D. Changsom, K. Chawansuntati, and J. Wipasa. 2010. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. International Immunopharmacology 10 (7):815–818. doi: 10.1016/j.intimp.2010.04.021.
  • Koshal, P., S. Jamwal, and P. Kumar. 2017. Glucagon-like Peptide-1 (GLP-1) and neurotransmitters signaling in epilepsy: An insight review. Neuropharmacology 136 (pt B):271–279. doi: 10.1016/j.neuropharm.2017.11.015.
  • Kuhad, A., and K. Chopra. 2007. Curcumin attenuates diabetic encephalopathy in rats: Behavioral and biochemical evidences. European Journal of Pharmacology 576 (1–3):34–42. doi: 10.1016/j.ejphar.2007.08.001.
  • Kukongviriyapan, U., P. Pannangpetch, V. Kukongviriyapan, W. Donpunha, K. Sompamit, and P. Surawattanawan. 2014. Curcumin protects against cadmium-induced vascular dysfunction, hypertension and tissue cadmium accumulation in mice. Nutrients 6 (3):1194–1208. doi: 10.3390/nu6031194.
  • Kumar, D., S. Basu, L. Parija, D. Rout, S. Manna, J. Dandapat, and P. R. Debata. 2016. Curcumin and Ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cells. Biomedicine & Pharmacotherapy 81:31–37.
  • Kumar, P. T., N. George, S. Antony, and C. S. Paulose. 2013. Curcumin restores diabetes induced neurochemical changes in the brain stem of Wistar rats. European Journal of Pharmacology 702 (1–3):323–331. doi: 10.1016/j.ejphar.2013.01.012.
  • Kumar, T. P., S. Antony, G. Gireesh, N. George, and C. Paulose. 2010. Curcumin modulates dopaminergic receptor, CREB and phospholipase C gene expression in the cerebral cortex and cerebellum of streptozotocin induced diabetic rats. Journal of Biomedical Science 17 (1):43. doi: 10.1186/1423-0127-17-43.
  • Kumar, T. P., S. Antony, S. Soman, K. P. Kuruvilla, N. George, and C. Paulose. 2011. Role of curcumin in the prevention of cholinergic mediated cortical dysfunctions in streptozotocin-induced diabetic rats. Molecular and Cellular Endocrinology 331 (1):10. doi: 10.1016/j.mce.2010.07.004.
  • Kumar, U., U. Sharma, and G. Rathi. 2017. Reversal of hypermethylation and reactivation of glutathione S-transferase pi 1 gene by curcumin in breast cancer cell line. Tumor Biology 39 1010428317692258. doi: 10.1177/1010428317692258.
  • Kumari, A., D. Dash, and R. Singh. 2015. Lipopolysaccharide (LPS) exposure differently affects allergic asthma exacerbations and its amelioration by intranasal curcumin in mice. Cytokine 76 (2):334–342. doi: 10.1016/j.cyto.2015.07.022.
  • Kunnumakkara, A. B., D. Bordoloi, G. Padmavathi, J. Monisha, N. K. Roy, S. Prasad, and B. B. Aggarwal. 2017. Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. British Journal of Pharmacology 174 (11):1325–1348. doi: 10.1111/bph.13621.
  • Kuriakose, M. A., K. Ramdas, B. Dey, S. Iyer, G. Rajan, K. K. Elango, A. Suresh, D. Ravindran, R. R. Kumar, P. R., et al. 2016. A randomized double-blind placebo-controlled phase iib trial of curcumin in oral leukoplakia. Cancer Prevention Research 9 (8):683–691.
  • Kurup, V. P., and C. S. Barrios. 2008. Immunomodulatory effects of curcumin in allergy. Molecular Nutrition & Food Research 52:1031–1039. doi: 10.1002/mnfr.200700293.
  • Kutluay, S. B., J. Doroghazi, M. E. Roemer, and S. J. Triezenberg. 2008. Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology 373 (2):239–247.
  • Kuttan, R., P. Sudheeran, and C. Josph. 1987. Turmeric and curcumin as topical agents in cancer therapy. Tumori 73 (1):29–31.
  • Kwak, H. J., M. J. Park, H. Cho, C. M. Park, S. I. Moon, H. C. Lee, I. C. Park, M. S. Kim, C. H. Rhee, and S. I. Hong. 2006. Transforming growth factor-β1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells. Molecular Cancer Research 4 (3):209–220. doi: 10.1158/1541-7786.MCR-05-0140.
  • Lakshmanan, A. P., K. Watanabe, R. A. Thandavarayan, F. R. Sari, H. Meilei, V. Soetikno, S. Arumugam, V. V. Giridharan, K. Suzuki, and M. Kodama. 2011. Curcumin attenuates hyperglycaemia-mediated AMPK activation and oxidative stress in cerebrum of streptozotocin-induced diabetic rat. Free Radical Research 45 (7):788–795. doi: 10.3109/10715762.2011.579121.
  • Lal, B., A. Kapoor, O. Asthana, P. Agrawal, R. Prasad, P. Kumar, and R. Srimal. 1999. Efficacy of curcumin in the management of chronic anterior uveitis. Phytotherapy Research 13 (4):318–322.
  • Lal, B., A. Kapoor, P. Agrawal, O. Asthana, and R. Srimal. 2000. Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytotherapy Research 14 (6):443–447.
  • Lang, A., N. Salomon, J. C. Y. Wu, U. Kopylov, A. Lahat, O. Har-Noy, J. Y. L. Ching, P. K. Cheong, B. Avidan, D. Gamus, et al. 2015. Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clinical Gastroenterology and Hepatology 13 (8):1444–1449.
  • Lao, C. D., M. T. Ruffin, D. Normolle, D. D. Heath, S. I. Murray, J. M. Bailey, M. E. Boggs, J. Crowell, C. L. Rock, and D. E. Brenner. 2006. Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine 6:10.
  • Leclercq, I. A., G. C. Farrell, C. Sempoux, A. Dela Peña, and Y. Horsmans. 2004. Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice. Journal of Hepatology 41 (6):926–934. doi: 10.1016/j.jhep.2004.08.010.
  • Lee, H. M., V. Patel, L. F. Shyur, and W. L. Lee. 2016. Copper supplementation amplifies the antitumor effect of curcumin in oral cancer cells. Phytomedicine 23 (12):1535–1544.
  • Lee, J. H., J. W. Kim, N. Y. Ko, S. H. Mun, E. Her, B. K. Kim, J. W. Han, H. Y. Lee, M. A. Beaven, Y. M. Kim, and W. S. Choi. 2008. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk. Journal of Allergy and Clinical Immunology 121 (5):1225–1231. doi: 10.1016/j.jaci.2007.12.1160.
  • Lee, S. J., and S. A. Langhans. 2012. Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis. BMC Cancer 12:44. doi:10.1186/1471-2407-12-44.
  • Lee, S. J., C. Krauthauser, V. Maduskuie, P. T. Fawcett, J. M. Olson, and S. A. Rajasekaran. 2011. Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo. BMC Cancer 11:144. doi:10.1186/1471-2407-11-144.
  • Lee, S. W., S. S. Nah, J. S. Byon, H. J. Ko, S. H. Park, S. J. Lee, W. Y. Shin, and D. K. Jin. 2011. Transient complete atrioventricular block associated with curcumin intake. International Journal of Cardiology 150 (2):e50–e52. doi: 10.1016/j.ijcard.2009.09.530.
  • Lee, W., and D. G. Lee. 2014. An antifungal mechanism of curcumin lies in membrane‐targeted action within Candida albicans. IUBMB Life 66 (11):780–785. doi: 10.1002/iub.1326.
  • Lelli, D., A. Sahebkar, T. P. Johnston, and C. Pedone. 2017. Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacological Research 115:133–148.
  • Lelli, D., C. Pedone, and A. Sahebkar. 2017. Curcumin and treatment of melanoma: The potential role of microRNAs. Biomedicine & Pharmacotherapy 88:832–834. doi: 10.1016/j.biopha.2017.01.078.
  • Lestari, M., and G. Indrayanto. 2014. Curcumin. In Profiles of drug substances, excipients, and related methodology, vol. 39, 113–204. Sand Diego, CA: Academic Press.
  • Lev-Ari, S., L. Strier, D. Kazanov, L. Madar-Shapiro, H. Dvory-Sobol, I. Pinchuk, B. Marian, D. Lichtenberg, and N. Arber. 2005. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clinical Cancer Research 11 (18):6738–6744.
  • Li, G., J. Bu, Y. Zhu, X. Xiao, Z. Liang, and R. Zhang. 2015a. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. International Journal of Clinical and Experimental Pathology 8 (12):15684–15695.
  • Li, M., S. Wu, Y. Li, and Y. Tian. 2015b. Combination of curcumin and piperine prevents formation of gallstones in C57BL6 mice fed on lithogenic diet: Whether NPC1L1/SREBP2 participates in this process? Lipids in Health and Disease 14:100. doi:10.1186/s12944-015-0106-2.
  • Liang, T., X. Zhang, W. Xue, S. Zhao, X. Zhang, and J. Pei. 2014. Curcumin induced human gastric cancer BGC-823 cells apoptosis by ROS-mediated ASK1-MKK4-JNK stress signaling pathway. International Journal of Molecular Sciences 15 (9):15754–15765. doi: 10.3390/ijms150915754.
  • Liang, Z., R. Wu, W. Xie, C. Xie, J. Wu, S. Geng, X. Li, M. Zhu, W. Zhu, J. Zhu, et al. 2017. Effects of curcumin on tobacco smoke‐induced hepatic MAPK pathway activation and epithelial-mesenchymal transition in vivo. Phytotherapy Research 31 (8):1230–1239.,
  • Lim, G. P., T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole. 2001. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. The Journal of Neuroscience 21 (21):8370–8377. doi: 10.1523/JNEUROSCI.21-21-08370.2001.
  • Lim, K. J., S. Bisht, E. E. Bar, A. Maitra, and C. G. Eberhart. 2011. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biology & Therapy 11:464–473. doi: 10.4161/cbt.11.5.14410.
  • Lin, J. K. 2007. Molecular targets of curcumin. In The molecular targets and therapeutic uses of curcumin in health and disease, 227–243. Boston, MA: Springer.
  • Lin, T. Y., C. W. Lu, C. C. Wang, Y. C. Wang, and S. J. Wang. 2011. Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: Possible relevance to its antidepressant mechanism. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (7):1785–1793. doi: 10.1016/j.pnpbp.2011.06.012.
  • Lin, X., Y. Chen, and Z. Liu. 2016. Effect and its molecular mechanisms of curcumin on pulmonary artery smooth muscle cells in rat model with chronic obstructive pulmonary disease. Zhejiang Da Xue Xue Bao Yi Xue Ban 45:469–476.
  • Liu, H., C. Wang, Z. Qiao, and Y. Xu. 2017. Protective effect of curcumin against myocardium injury in ischemia reperfusion rats. Pharmaceutical Biology 55 (1):1144–1148. doi: 10.1080/13880209.2016.1214741.
  • Liu, J., X. He, P. Zhen, S. Zhou, and X. Li. 2016. Inflammatory cytokines and oxidative stress markers in the inhibition of osteoarthritis by curcumin. Zhejiang Da Xue Xue Bao Yi Xue Ban 45 (5):461–468.
  • Liu, L., C. Duan, Z. Ma, and G. Xu. 2015. Curcumin inhibited rat colorectal carcinogenesis by activating PPAR-γ: An experimental study. Zhongguo Zhongguo Zhong Xi Yi Jie He Za Zhi 35:471–475.
  • Liu, L., Y. Shang, M. Li, X. Han, J. Wang, and J. Wang. 2015. Curcumin ameliorates asthmatic airway inflammation by activating nuclear factor‐E2‐related factor 2/haem oxygenase (HO)‐1 signalling pathway. Clinical and Experimental Pharmacology and Physiology 42 (5):520–529. doi: 10.1111/1440-1681.12384.
  • Liu, S., Y. Cao, M. Qu, Z. Zhang, L. Feng, Z. Ye, M. Xiao, S. T. Hou, R. Zheng, and Z. Han. 2016. Curcumin protects against stroke and increases levels of Notch intracellular domain. Neurological Research 38 (6):553–559. doi: 10.1080/01616412.2016.1187804.
  • Liu, W. L., J. M. Chang, I. W. Chong, Y. L. Hung, Y. H. Chen, W. T. Huang, H. F. Kuo, C. C. Hsieh, and P. L. Liu. 2017. Curcumin inhibits LIN-28A through the activation of miRNA-98 in the lung cancer cell line A549. Molecules 22:E929. doi: 10.3390/molecules22060929.
  • Liu, Y., J. Zhou, Y. Hu, J. Wang, and C. Yuan. 2017. Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter. Molecular and Cellular Biochemistry 425 (1–2):47–58. doi: 10.1007/s11010-016-2861-4.
  • Liu, Z., J. Liu, L. Zhao, H. Geng, J. Ma, Z. Zhang, D. Yu, and C. Zhong. 2017. Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells. International Journal of Oncology 50 (4):1321–1329. doi: 10.3892/ijo.2017.3887.
  • Lopresti, A. L. 2017. Curcumin for neuropsychiatric disorders: A review of in vitro, animal and human studies. Journal of Psychopharmacology 31 (3):287–302. doi: 10.1177/0269881116686883.
  • Lopresti, A. L., and P. D. Drummond. 2017. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebocontrolled study. Journal of Affective Disorders 207:188–196.
  • Lopresti, A. L., M. Maes, G. L. Maker, S. D. Hood, and P. D. Drummond. 2014. Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study. Journal of Affective Disorders 167:368–375. doi: 10.1016/j.jad.2014.06.001.
  • Lopresti, A. L., M. Maes, M. J. Meddens, G. L. Maker, E. Arnoldussen, and P. D. Drummond. 2015. Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change. European Neuropsychopharmacology 25 (1):38–50. doi: 10.1016/j.euroneuro.2014.11.015.
  • Lu, M., N. Yin, W. Liu, X. Cui, S. Chen, and E. Wang. 2017. Curcumin ameliorates diabetic nephropathy by suppressing NLRP3 inflammasome signaling. BioMed Research International 2017:1–10. doi: 10.1155/2017/1516985.
  • Lu, Z., Y. Shen, T. Wang, M. Cui, Z. Wang, H. Zhao, and Q. Dong. 2014. Curcumin promotes neurite outgrowth via reggie-1/flotillin-2 in cortical neurons. Neuroscience Letters 559:7–12. doi: 10.1016/j.neulet.2013.11.029.
  • Lüer, S. C., J. Goette, R. Troller, and C. Aebi. 2014. Synthetic versus natural curcumin: Bioequivalence in an in vitro oral mucositis model. BMC Complementary and Alternative Medicine 14:53. doi:10.1186/1472-6882-14-53.
  • Lüer, S., R. Troller, M. Jetter, V. Spaniol, and C. Aebi. 2011. Topical curcumin can inhibit deleterious effects of upper respiratory tract bacteria on human oropharyngeal cells in vitro: Potential role for patients with cancer therapy induced mucositis? Supportive Care in Cancer 19 (6):799–806. doi: 10.1007/s00520-010-0894-x.
  • Luthra, P. M., and N. Lal. 2016. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma. European Journal of Medicinal Chemistry 109:23–35. doi: 10.1016/j.ejmech.2015.11.049.
  • Lv, F. H., H. L. Yin, Y. Q. He, H. M. Wu, J. Kong, X. Y. Chai, and S. R. Zhang. 2016. Effects of curcumin on the apoptosis of cardiomyocytes and the expression of NF-κB, PPAR-γ and Bcl-2 in rats with myocardial infarction injury. Experimental and Therapeutic Medicine 12 (6):3877–3884. doi: 10.3892/etm.2016.3858.
  • Lv, Y., N. Lei, D. Wang, Z. An, G. Li, F. Han, H. Liu, and L. Liu. 2014. Protective effect of curcumin against cytomegalovirus infection in Balb/c mice. Environmental Toxicology and Pharmacology 37 (3):1140–1147.
  • Ma, W., Q. Guo, Y. Li, X. Wang, J. Wang, and P. Tu. 2017. Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy. European Journal of Pharmaceutics and Biopharmaceutics 112:209–223.
  • Madhavi, M., K. Madhavi, and A. Jithan. 2012. Preparation and in vitro/in vivo characterization of curcumin microspheres intended to treat Colon cancer. Journal of Pharmacy & Bioallied Sciences 4:164–171.
  • Magalhães, L. G., C. B. Machado, E. R. Morais, and É. Bueno de Carvalho Moreira, C. S. Soares, S. H. da Silva, A. A. Da Silva Filho, and V. Rodrigues. 2009. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitology Research 104:1197–1201.
  • Mahammedi, H., E. Planchat, M. Pouget, X. Durando, H. Curé, L. Guy, I. Van-Praagh, L. Savareux, M. Atger, M. Bayet-Robert, et al. 2016. The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: A pilot phase II study. Oncology 90 (2):69–78., doi: 10.1159/000441148.
  • Maheshwari, R. K., A. K. Singh, J. Gaddipati, and R. C. Srimal. 2006. Multiple biological activities of curcumin: A short review. Life Sciences 78 (18):2081–2087. doi: 10.1016/j.lfs.2005.12.007.
  • Maithili Karpaga Selvi, N., M. G. Sridhar, R. P. Swaminathan, and R. Sripradha. 2015. Curcumin attenuates oxidative stress and activation of redox-sensitive kinases in high fructose-and high-fatfed male Wistar rats. Scientia Pharmaceutica 83:159–175.
  • Maithilikarpagaselvi, N., M. G. Sridhar, R. P. Swaminathan, and B. Zachariah. 2016. Curcumin prevents inflammatory response, oxidative stress and insulin resistance in high fructose fed male Wistar rats: Potential role of serine kinases. Chemico-Biological Interactions 244:187–194. doi: 10.1016/j.cbi.2015.12.012.
  • Maithilikarpagaselvi, N., M. G. Sridhar, R. P. Swaminathan, R. Sripradha, and B. Badhe. 2016. Curcumin inhibits hyperlipidemia and hepatic fat accumulation in high-fructose-fed male Wistar rats. Pharmaceutical Biology 54 (12):2857–2863. doi: 10.1080/13880209.2016.1187179.
  • Malathi, M., and D. M. Thappa. 2016. Topical therapy in vitiligo: What is new? Pigment International 3:1–4. doi: 10.4103/2349-5847.184247.
  • Mandroli, P. S., and K. Bhat. 2013. An in-vitro evaluation of antibacterial activity of curcumin against common endodontic bacteria. Journal of Applied Pharmaceutical Science 3:106–108.
  • Mantzorou, M., E. Pavlidou, G. Vasios, E. Tsagalioti, and C. Giaginis. 2018. Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data. Phytotherapy Research 32 (6):957–975. doi: 10.1002/ptr.6037.
  • Marathe, S. A., I. Dasgupta, D. P. Gnanadhas, and D. Chakravortty. 2011. Multifaceted roles of curcumin: Two sides of a coin! Expert Opinion on Biological Therapy 11 (11):1485–1499. doi: 10.1517/14712598.2011.623124.
  • Martins, C., D. Da Silva, A. Neres, T. Magalhaes, G. Watanabe, L. Modolo, A. Sabino, A. De Fátima, and M. De Resende. 2008. Curcumin as a promising antifungal of clinical interest. Journal of Antimicrobial Chemotherapy 63 (2):337–339. doi: 10.1093/jac/dkn488.
  • Mazumder, A., K. Raghavan, J. Weinstein, K. W. Kohn, and Y. Pommier. 1995. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochemical Pharmacology 49 (8):1165–1170.
  • Mazumder, A., N. Neamati, S. Sunder, J. Schulz, H. Pertz, E. Eich, and Y. Pommier. 1997. Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. Journal of Medicinal Chemistry 40 (19):3057–3063.
  • Mehanny, M., R. M. Hathout, A. S. Geneidi, and S. Mansour. 2016. Exploring the use of nanocarrier systems to deliver the magical molecule; curcumin and its derivatives. Journal of Controlled Release 225:1–30. doi: 10.1016/j.jconrel.2016.01.018.
  • Meidan, I., G. Sellam, S. Simaan, I. Zeevi, E. Waldman, and M. Weintraub. 2013. Topical curcumin for the prevention of oral mucositis in pediatric patients: Case series. Alternative Therapies in Health and Medicine 19:21–24.
  • Miao, M., B. Cheng, and M. Li. 2015. Effect of curcumin on diabetic rat model of cerebral ischemia. Pakistan Journal of Pharmaceutical Sciences 28:401–405.
  • Miao, Y., S. Zhao, Y. Gao, R. Wang, Q. Wu, H. Wu, and T. Luo. 2016. Curcumin pretreatment attenuates inflammation and mitochondrial dysfunction in experimental stroke: The possible role of Sirt1 signaling. Brain Research Bulletin 121:9–15. doi: 10.1016/j.brainresbull.2015.11.019.
  • Mimche, P. N., D. Taramelli, and L. Vivas. 2011. The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria. Malaria Journal 10 (Suppl 1):S10. doi: 10.1186/1475-2875-10-S1-S10.
  • Mimeault, M., and S. K. Batra. 2011. Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chinese Medicine 6 (1):31. doi: 10.1186/1749-8546-6-31.
  • Mirgani, M. T., B. Isacchi, M. Sadeghizadeh, F. Marra, A. R. Bilia, S. J. Mowla, F. Najafi, and E. Babaei. 2014. Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells. International Journal of Nanomedicine 9:403–417.
  • Mishra, A., and B. C. Das. 2015. Curcumin as an anti-human papillomavirus and anti-cancer compound. Future Oncology 11 (18):2487–2490.
  • Mishra, D., S. Singh, and G. Narayan. 2016. Curcumin induces apoptosis in pre-b acute lymphoblastic leukemia cell lines via parp-1 cleavage. Asian Pacific Journal of Cancer Prevention 17:3865–3869.
  • Mishra, S., and K. Palanivelu. 2008. The effect of curcumin (turmeric) on Alzheimer’s disease: An overview. Annals of Indian Academy of Neurology 11 (1):13–19.
  • Moghtaderi, H., H. Sepehri, and F. Attari. 2017. Combination of arabinogalactan and curcumin induces apoptosis in breast cancer cells in vitro and inhibits tumor growth via overexpression of p53 level in vivo. Biomedicine & Pharmacotherapy 88:582–594.
  • Mohammadi, A., A. Sahebkar, M. Iranshahi, M. Amini, R. Khojasteh, M. Ghayour, ‐Mobarhan, and G. A. Ferns. 2013. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: A randomized crossover trial. Phytotherapy Research 27 (3):374–379. doi: 10.1002/ptr.4715.
  • Molina-Jijón, E., O. E. Aparicio-Trejo, R. Rodríguez-Muñoz, J. C. León-Contreras, M. del Carmen Cárdenas-Aguayo, O. N. Medina-Campos, E. Tapia, L. G. Sánchez-Lozada, R. Hernández-Pando, and J. L. Reyes. 2016. The nephroprotection exerted by curcumin in maleate‐induced renal damage is associated with decreased mitochondrial fission and autophagy. BioFactors 42:686–702. doi: 10.1002/biof.1313.
  • Montgomery, A., T. Adeyeni, K. San, R. M. Heuertz, and U. R. Ezekiel. 2016. Curcumin sensitizes silymarin to exert synergistic anticancer activity in Colon cancer cells. Journal of Cancer 7 (10):1250–1257.
  • Morrone, M. D. S., C. E. Schnorr, G. A. Behr, J. Gasparotto, R. C. Bortolin, K. S. Moresco, L. Bittencourt, A. Zanotto-Filho, D. P. Gelain, and J. C. F. Moreira. 2016. Oral administration of curcumin relieves behavioral alterations and oxidative stress in the frontal cortex, hippocampus, and striatum of ovariectomized Wistar rats. The Journal of Nutritional Biochemistry 32:181–188. doi: 10.1016/j.jnutbio.2016.03.010.
  • Morsy, M. A., and M. A. El-Moselhy. 2013. Mechanisms of the protective effects of curcumin against indomethacin-induced gastric ulcer in rats. Pharmacology 91 (5–6):267–274. doi: 10.1159/000350190.
  • Mouler Rechtman, M., O. Har-Noy, I. Bar-Yishay, S. Fishman, Y. Adamovich, Y. Shaul, Z. Halpern, and A. Shlomai. 2010. Curcumin inhibits hepatitis B virus via down‐regulation of the metabolic coactivator PGC‐1α. FEBS Letters 584 (11):2485–2490. doi: 10.1016/j.febslet.2010.04.067.
  • Muglikar, S., K. C. Patil, S. Shivswami, and R. Hegde. 2013. Efficacy of curcumin in the treatment of chronic gingivitis: A pilot study. Oral Health & Preventive Dentistry 11:81–86.
  • Mythri, R. B., and M. M. Srinivas Bharath. 2012. Curcumin: A potential neuroprotective agent in Parkinson’s disease. Current Pharmaceutical Design 18:91–99.
  • Nabavi, S. F., M. Daglia, A. H. Moghaddam, S. Habtemariam, and S. M. Nabavi. 2014. Curcumin and liver disease: From chemistry to medicine. Comprehensive Reviews in Food Science and Food Safety 13 (1):62–77. doi: 10.1111/1541-4337.12047.
  • Nakagawa, Y., S. Mukai, S. Yamada, M. Matsuoka, E. Tarumi, T. Hashimoto, C. Tamura, A. Imaizumi, J. Nishihira, and T. Nakamura. 2014. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: A randomized, double-blind, placebo-controlled prospective study. Journal of Orthopaedic Science 19 (6):933–939. doi: 10.1007/s00776-014-0633-0.
  • Nandal, S., A. Dhir, A. Kuhad, S. Sharma, and K. Chopra. 2009. Curcumin potentiates the antiinflammatory activity of cyclooxygenase inhibitors in the cotton pellet granuloma pouch model. Methods and Findings in Experimental and Clinical Pharmacology 31 (2):89–93.
  • Nanji, A. A., K. Jokelainen, A. Rahemtulla, L. Miao, F. Fogt, H. Matsumoto, S. R. Tahan, and G. L. Su. 1999. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30 (4):934–943. doi: 10.1002/hep.510300402.
  • Neerati, P., R. Devde, and A. K. Gangi. 2014. Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type‐2 diabetes mellitus. Phytotherapy Research 28 (12):1796–1800.
  • Neerati, P., Y. A. Sudhakar, and J. R. Kanwar. 2013. Curcumin regulates Colon cancer by inhibiting P-glycoprotein in in-situ cancerous Colon perfusion rat model. Journal of Cancer Science and Therapy 5:313–319.
  • Ng, Q. X., S. S. H. Koh, H. W. Chan, and C. Y. X. Ho. 2017. Clinical use of curcumin in depression: A meta-analysis. Journal of the American Medical Directors Association 18 (6):503–508. doi: 10.1016/j.jamda.2016.12.071.
  • Niazvand, F., L. Khorsandi, M. Abbaspour, M. Orazizadeh, N. Varaa, M. Maghzi, and K. Ahmadi. 2017. Curcumin-loaded poly lactic-co-glycolic acid nanoparticles effects on Mono-iodoacetate-induced osteoarthritis in rats. Veterinary Research Forum 8:155–161.
  • Niederau, C., and E. Göpfert. 1999. The effect of chelidonium-and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebocontrolled double-blind study. Medizinische Klinik 94 (8):425–430.
  • Noorafshan, A., and S. Ashkani-Esfahani. 2013. A review of therapeutic effects of curcumin. Current Pharmaceutical Design 19:2032–2046.
  • Noorafshan, A., M. A. Abdollahifar, S. Karbalay-Doust, R. Asadi-Golshan, and A. Rashidian-Rashidabadi. 2015. Sertraline and curcumin prevent stress-induced morphological changes of dendrites and neurons in the medial prefrontal cortex of rats. Folia Neuropathologica 53:69–79.
  • Novaes, R. D., M. V. P. Sartini, J. P. F. Rodrigues, R. V. Gonçalves, E. C. Santos, R. L. M. Souza, and I. S. Caldas. 2016. Curcumin enhances the anti-Trypanosoma cruzi activity of benznidazole-based chemotherapy in acute experimental Chagas disease. Antimicrobial Agents and Chemotherapy 60 (6):3355–3364.
  • Ohtsuka, K., and T. Suzuki. 2000. Roles of molecular chaperones in the nervous system. Brain Research Bulletin 53 (2):141–146.
  • Öner-İyidoğan, Y., H. Koçak, M. Seyidhanoğlu, F. Gürdöl, A. Gülçubuk, F. Yildirim, A. Çevik, and M. Uysal. 2013. Curcumin prevents liver fat accumulation and serum fetuin-A increase in rats fed a high-fat diet. Journal of Physiology and Biochemistry 69 (4):677–686.
  • Öner-İyidoğan, Y., S. Tanrıkulu-Küçük, M. Seyithanoğlu, H. Koçak, S. Doğru-Abbasoğlu, A. F. Aydın, Ş. Beyhan-Özdaş, H. Yapışlar, and N. Koçak-Toker. 2014. Effect of curcumin on hepatic heme oxygenase 1 expression in high fat diet fed rats: Is there a triangular relationship? Canadian Journal of Physiology and Pharmacology 92 (10):805–812. doi: 10.1139/cjpp-2014-0174.
  • Ou, J. L., Y. Mizushina, S. Y. Wang, D. Y. Chuang, M. Nadar, and W. L. Hsu. 2013. Structure-activity relationship analysis of curcumin analogues on anti‐influenza virus activity. FEBS Journal 280 (22):5829–5840.
  • Padilla-S, L., A. Rodríguez, M. M. Gonzales, J. C. Gallego-G, and J. C. Castaño-O. 2014. Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro. Archives of Virology 159 (3):573–579.
  • Pan, J., H. Li, J. F. Ma, Y. Y. Tan, Q. Xiao, J. Q. Ding, and S. D. Chen. 2012. Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease through suppressing mitochondria dysfunction. Translational Neurodegeneration 1 (1):16. doi: 10.1186/2047-9158-1-16.
  • Pan, M. H., T. M. Huang, and J. K. Lin. 1999. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolism and Disposition 27:486–494.
  • Pan, Z., N. Deng, Z. Zou, and G. Chen. 2017. The effect of curcumin on bladder tumor in rat model. European Review for Medical and Pharmacological Sciences 21:884–889.
  • Panahi, Y., A. Saadat, F. Beiraghdar, and A. Sahebkar. 2014. Adjuvant therapy with bioavailability‐boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: A randomized double‐blind placebo‐controlled trial. Phytotherapy Research 28 (10):1461–1467.
  • Panda, A. K., D. Chakraborty, I. Sarkar, T. Khan, and G. Sa. 2017. New insights into therapeutic activity and anticancer properties of curcumin. Journal of Experimental Pharmacology Volume 9:31–45.
  • Pandareesh, M., M. Shrivash, H. N. Kumar, K. Misra, and M. S. Bharath. 2016. Curcumin monoglucoside shows improved bioavailability and mitigates rotenone induced neurotoxicity in cell and Drosophila models of Parkinson’s disease. Neurochemical Research 41 (11):3113–3128. doi: 10.1007/s11064-016-2034-6.
  • Pandey, A., K. Vishnoi, S. Mahata, S. C. Tripathi, S. P. Misra, V. Misra, R. Mehrotra, M. Dwivedi, and A. C. Bharti. 2015. Berberine and curcumin target survivin and STAT3 in gastric cancer cells and synergize actions of standard chemotherapeutic 5-fluorouracil. Nutrition and Cancer 67 (8):1295–1306.
  • Papiez, M. A. 2013. The influence of curcumin on the action of etoposide in a rat acute myeloid leukemia cell line. Folia Medica Cracoviensia 53:61–72.
  • Park, S. G., D. H. Baek, K. M. Lee, S. Y. Oh, G. A. Song, D. Y. Park, S. Ahn, and N. Shin. 2016. Unusual presentation of erdheim‐Chester disease. Journal of Digestive Diseases 17 (12):837–840. doi: 10.1111/1751-2980.12421.
  • Patel, P. B., V. R. Thakkar, and J. S. Patel. 2015. Cellular effect of curcumin and citral combination on breast cancer cells: Induction of apoptosis and cell cycle arrest. Journal of Breast Cancer 18 (3):225–234.
  • Patel, S. S., and M. Udayabanu. 2013. Effect of Urtica dioica on memory dysfunction and hypoalgesia in an experimental model of diabetic neuropathy. Neuroscience Letters 552:114–119. doi: 10.1016/j.neulet.2013.07.029.
  • Patil, B. S., G. Jayaprakasha, K. Chidambara Murthy, and A. Vikram. 2009. Bioactive compounds: Historical perspectives, opportunities, and challenges. Journal of Agricultural and Food Chemistry 57 (18):8142–8160.
  • Pearson-Smith, J. N., and M. Patel. 2017. Metabolic dysfunction and oxidative stress in epilepsy. International Journal of Molecular Sciences 18 (11):E2365. doi: 10.3390/ijms18112365.
  • Peeyush, K. T., G. Gireesh, M. Jobin, and C. Paulose. 2009. Neuroprotective role of curcumin in the cerebellum of streptozotocin-induced diabetic rats. Life Sciences 85 (19–20):704–710.
  • Perez-Arriaga, L., M. Mendoza-Magana, R. Cortes-Zarate, A. Corona-Rivera, L. Bobadilla-Morales, R. Troyo-Sanromán, and M. Ramirez-Herrera. 2006. Cytotoxic effect of curcumin on Giardia lamblia trophozoites. Acta Tropica 98:152–161. doi: 10.1016/j.actatropica.2006.03.005.
  • Perrone, D., F. Ardito, G. Giannatempo, M. Dioguardi, G. Troiano, L. Lo Russo, A. De Lillo, L. Laino, and L. Lo Muzio. 2015. Biological and therapeutic activities, and anticancer properties of curcumin. Experimental and Therapeutic Medicine 10 (5):1615–1623. doi: 10.3892/etm.2015.2749.
  • Phrommintikul, A., and N. Chattipakorn. 2006. Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death. International Journal of Cardiology 112 (2):142–152. doi: 10.1016/j.ijcard.2005.11.106.
  • Pinsornsak, P., and S. Niempoog. 2012. The efficacy of Curcuma longa L. extract as an adjuvant therapy in primary knee osteoarthritis: A randomized control trial. Journal of the Medical Association of Thailand 95:S51–S58.
  • Portincasa, P., L. Bonfrate, M. L. Scribano, A. Kohn, N. Caporaso, D. Festi, M. C. Campanale, T. Di Rienzo, M. Guarino, and M. Taddia. 2016. Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome. Journal of Gastrointestinal & Liver Diseases 25:151–157.
  • Prasad, S., and A. K. Tyagi. 2015. Curcumin and its analogues: A potential natural compound against HIV infection and AIDS. Food & Function 6:3412–3419.
  • Prasad, S., S. C. Gupta, A. K. Tyagi, and B. B. Aggarwal. 2014. Curcumin, a component of golden spice: From bedside to bench and back. Biotechnology Advances 32 (6):1053–1064.
  • Prucksunand, C., B. Indrasukhsri, M. Leethochawalit, and K. Hungspreugs. 2001. Phase II clinical trial on effect of the long turmeric (Curcuma longa Linn) on healing of peptic ulcer. The Southeast Asian Journal of Tropical Medicine and Public Health 32:208–215.
  • Prusty, B. K., and B. C. Das. 2005. Constitutive activation of transcription factor AP‐1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP‐1 activity in HeLa cells by curcumin. International Journal of Cancer 113 (6):951–960.
  • Pulido-Moran, M., J. Moreno-Fernandez, C. Ramirez-Tortosa, and M. Ramirez-Tortosa. 2016. Curcumin and health. Molecules (Basel, Switzerland) 21 (3):264.
  • Pulikkotil, S., and S. Nath. 2015. Effects of curcumin on crevicular levels of IL‐1β and CCL28 in experimental gingivitis. Australian Dental Journal 60 (3):317–327. doi: 10.1111/adj.12340.
  • Qadir, M. I., S. Naqvi, and S. A. Muhammad. 2016. Curcumin: A polyphenol with molecular targets for cancer control. Asian Pacific Journal of Cancer Prevention 17:2735–2739.
  • Qin, Y., L. Lin, Y. Chen, S. Wu, X. Si, H. Wu, X. Zhai, Y. Wang, L. Tong, B. Pan, et al. 2014. Curcumin inhibits the replication of enterovirus 71 in vitro. Acta Pharmaceutica Sinica B 4 (4):284–294.,
  • Qiu, Y., T. Yu, W. Wang, K. Pan, D. Shi, and H. Sun. 2014. Curcumin-induced melanoma cell death is associated with mitochondrial permeability transition pore (mPTP) opening. Biochemical and Biophysical Research Communications 448 (1):15–21. doi: 10.1016/j.bbrc.2014.04.024.
  • Qualls, Z., D. Brown, C. Ramlochansingh, L. L. Hurley, and Y. Tizabi. 2014. Protective effects of curcumin against rotenone and salsolinol-induced toxicity: Implications for Parkinson’s disease. Neurotoxicity Research 25 (1):81–89. doi: 10.1007/s12640-013-9433-0.
  • Quispe-Soto, E. T., and G. M. Calaf. 2016. Effect of curcumin and paclitaxel on breast carcinogenesis. International Journal of Oncology 49 (6):2569–2577.
  • Rahimi, H. R., A. H. Mohammadpour, M. Dastani, M. R. Jaafari, K. Abnous, M. G. Mobarhan, and R. K. Oskuee. 2016. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: A randomized clinical trial. Avicenna Journal of Phytomedicine 6:567–577.
  • Rahimnia, A. R., Y. Panahi, G. Alishiri, M. Sharafi, and A. Sahebkar. 2015. Impact of supplementation with curcuminoids on systemic inflammation in patients with knee osteoarthritis: Findings from a randomized double-blind placebo-controlled trial. Drug Research 65:521–525.
  • Rahmani, S., S. Asgary, G. Askari, M. Keshvari, M. Hatamipour, A. Feizi, and A. Sahebkar. 2016. Treatment of non‐alcoholic fatty liver disease with curcumin: A randomized placebo‐controlled trial. Phytotherapy Research 30 (9):1540–1548. doi: 10.1002/ptr.5659.
  • Ramachandran, C., S. M. Nair, E. Escalon, and S. J. Melnick. 2012. Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force in brain tumor cell lines. Journal of Complementary and Integrative Medicine 9:20. doi:10.1515/1553-3840.1614.
  • Rana, A., and S. Misra-Bhattacharya. 2013. Current drug targets for helminthic diseases. Parasitology Research 112 (5):1819–1831.
  • Rana, C., H. Piplani, V. Vaish, B. Nehru, and S. Sanyal. 2015. Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in Colon cancer. Tumor Biology 36 (8):5999–6010.
  • Rao, E. V., and P. Sudheer. 2011. Revisiting curcumin chemistry part I: A new strategy for the synthesis of curcuminoids. Indian Journal of Pharmaceutical Sciences 73:262–270.
  • Rao, J., R. Zhang, G. Chen, F. Li, and R. Huang. 2015. Inhibitory effect of curcumin on proliferation of CD34 (+) acute myeloid leukemia cells and its mechanism. Zhongguo Shi Yan Xue Ye Xue Za Zhi 23 (4):1005–1008.
  • Rashid, K., S. Chowdhury, S. Ghosh, and P. C. Sil. 2017. Curcumin attenuates oxidative stress induced NFκB mediated inflammation and endoplasmic reticulum dependent apoptosis of splenocytes in diabetes. Biochemical Pharmacology 143:140–155. doi: 10.1016/j.bcp.2017.07.009.
  • Ravindranath, V., and N. Chandrasekhara. 1981. In vitro studies on the intestinal absorption of curcumin in rats. Toxicology 20:251–257.
  • Ray, B., and D. K. Lahiri. 2009. Neuroinflammation in Alzheimer’s disease: Different molecular targets and potential therapeutic agents including curcumin. Current Opinion in Pharmacology 9 (4):434–444. doi: 10.1016/j.coph.2009.06.012.
  • Refolo, L. M., M. A. Pappolla, J. LaFrancois, B. Malester, S. D. Schmidt, T. ThomasBryant, G. S. Tint, R. Wang, M. Mercken, S. S. Petanceska, et al. 2001. A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer’s disease. Neurobiology of Disease 8 (5):890–899. doi: 10.1006/nbdi.2001.0422.
  • Reuter, S., J. Charlet, T. Juncker, M. H. Teiten, M. Dicato, and M. Diederich. 2009. Effect of curcumin on nuclear factor κB signaling pathways in human chronic myelogenous K562 leukemia cells. Annals of the New York Academy of Sciences 1171 (1):436–447. doi: 10.1111/j.1749-6632.2009.04731.x.
  • Reyes-Gordillo, K., J. Segovia, M. Shibayama, V. Tsutsumi, P. Vergara, M. G. Moreno, and P. Muriel. 2008. Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: Role of TGF-beta modulation and oxidative stress. Fundamental & Clinical Pharmacology 22 (4):417–427.
  • Rice, K. M., N. D. Manne, M. B. Kolli, P. S. Wehner, L. Dornon, R. Arvapalli, V. Selvaraj, A. Kumar, and E. R. Blough. 2016. Curcumin nanoparticles attenuate cardiac remodeling due to pulmonary arterial hypertension. Artificial Cells, Nanomedicine, and Biotechnology 44 (8):1909–1916. doi: 10.3109/21691401.2015.1111235.
  • Rinwa, P., A. Kumar, and S. Garg. 2013. Suppression of neuroinflammatory and apoptotic signaling Cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression. PLoS One 8 (4):e61052.
  • Rivera-Espinoza, Y., and P. Muriel. 2009. Pharmacological actions of curcumin in liver diseases or damage. Liver International 29 (10):1457–1466.
  • Rodriguez, G. A., A. H. Shah, Z. C. Gersey, S. S. Shah, A. Bregy, R. J. Komotar, and R. M. Graham. 2016. Investigating the therapeutic role and molecular biology of curcumin as a treatment for glioblastoma. Therapeutic Advances in Medical Oncology 8 (4):248–260. doi: 10.1177/1758834016643518.
  • Rudrappa, T., and H. P. Bais. 2008. Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. Journal of Agricultural and Food Chemistry 56 (6):1955–1962. doi: 10.1021/jf072591j.
  • Ryan, J. L., C. E. Heckler, M. Ling, A. Katz, J. P. Williams, A. P. Pentland, and G. R. Morrow. 2013. Curcumin for radiation dermatitis: A randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiation Research 180 (1):34–43. doi: 10.1667/RR3255.1.
  • Sadeghzadeh, H., Y. Pilehvar-Soltanahmadi, A. Akbarzadeh, H. Dariushnejad, F. Sanjarian, and N. Zarghami. 2017. The effects of nanoencapsulated Curcumin-Fe3O4 on proliferation and hTERT gene expression in lung cancer cells. Anti-Cancer Agents in Medicinal Chemistry 17:1363–1373.
  • Sahebkar, A., A. F. Cicero, L. E. Simental-Mendía, B. B. Aggarwal, and S. C. Gupta. 2016. Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research 107:234–242. doi: 10.1016/j.phrs.2016.03.026.
  • Sahebkar, A., A. Mohammadi, A. Atabati, S. Rahiman, S. Tavallaie, M. Iranshahi, S. Akhlaghi, G. A. Ferns, and M. Ghayour, ‐Mobarhan. 2013. Curcuminoids modulate pro‐oxidant- antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytotherapy Research 27 (12):1883–1888. doi: 10.1002/ptr.4952.
  • Saini, S., S. Arora, S. Majid, V. Shahryari, Y. Chen, G. Deng, S. Yamamura, K. Ueno, and R. Dahiya. 2011. Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prevention Research 4 (10):1698–1709. doi: 10.1158/1940-6207.CAPR-11-0267.
  • Sandhir, R., A. Yadav, A. Mehrotra, A. Sunkaria, A. Singh, and S. Sharma. 2014. Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington’s disease. Neuromolecular Medicine 16 (1):106–118. doi: 10.1007/s12017-013-8261-y.
  • Sankrityayan, H., and A. S. Majumdar. 2016. Curcumin and folic acid abrogated methotrexate induced vascular endothelial dysfunction. Canadian Journal of Physiology and Pharmacology 94 (1):89–96.
  • Sannia, A. 2010. Phytotherapy with a mixture of dry extracts with hepato-protective effects containing artichoke leaves in the management of functional dyspepsia symptoms. Minerva Gastroenterol Dietol 56:93–99.
  • Santos, A., T. Lopes, M. Oleastro, I. Gato, P. Floch, L. Benejat, P. Chaves, T. Pereira, E. Seixas, J. Machado, and A. Guerreiro. 2015. Curcumin inhibits gastric inflammation induced by Helicobacter pylori infection in a mouse model. Nutrients 7 (1):306–320. doi: 10.3390/nu7010306.
  • Sasaki, H., Y. Sunagawa, K. Takahashi, A. Imaizumi, H. Fukuda, T. Hashimoto, H. Wada, Y. Katanasaka, H. Kakeya, M. Fujita, et al. 2011. Innovative preparation of curcumin for improved oral bioavailability. Biological & Pharmaceutical Bulletin 34 (5):660–665.,
  • Satoskar, R., S. Shah, and S. Shenoy. 1986. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. International Journal of Clinical Pharmacology & Toxicology 24:651–654.
  • Saydmohammed, M., D. Joseph, and V. Syed. 2010. Curcumin suppresses constitutive activation of STAT‐3 by up‐regulating protein inhibitor of activated STAT‐3 (PIAS‐3) in ovarian and endometrial cancer cells. Journal of Cellular Biochemistry 110:447–456.
  • Scapagnini, G., C. Colombrita, M. Amadio, V. D'Agata, E. Arcelli, M. Sapienza, A. Quattrone, and V. Calabrese. 2006. Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxidants & Redox Signaling 8 (3–4):395–403. doi: 10.1089/ars.2006.8.395.
  • Schoonderwoerd, B. A., M. D. Smit, L. Pen, and I. C. Van Gelder. 2008. New risk factors for atrial fibrillation: Causes of ‘not-so-lone atrial fibrillation.’ Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology 10 (6):668–673.
  • Senft, C., M. Polacin, M. Priester, V. Seifert, D. Kögel, and J. Weissenberger. 2010. 10:491. The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer 10:491. doi:10.1186/14712407-10-491.
  • Serafini, M. M., M. Catanzaro, M. Rosini, M. Racchi, and C. Lanni. 2017. Curcumin in Alzheimer’s disease: Can we think to new strategies and perspectives for this molecule? Pharmacological Research 124:146–155. doi: 10.1016/j.phrs.2017.08.004.
  • Sha, J., J. Li, W. Wang, L. Pan, J. Cheng, L. Li, H. Zhao, and W. Lin. 2016. Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling. Biomedicine & Pharmacotherapy 84:177–184. doi: 10.1016/j.biopha.2016.09.037.
  • Shah, A., and S. Amini-Nik. 2017. The role of phytochemicals in the inflammatory phase of wound healing. International Journal of Molecular Sciences 18 (5):1068. doi: 10.3390/ijms18051068.
  • Shah, F. A., S. A. Gim, J. H. Sung, S. J. Jeon, M. O. Kim, and P. O. Koh. 2016a. Identification of proteins regulated by curcumin in cerebral ischemia. Journal of Surgical Research 201 (1):141–148. doi: 10.1016/j.jss.2015.10.025.
  • Shah, K., S. Mirza, U. Desai, N. Jain, and R. Rawal. 2016b. Synergism of curcumin and cytarabine in the down regulation of multi-drug resistance genes in acute myeloid leukemia. Anti-Cancer Agents in Medicinal Chemistry 16 (1):128–135.
  • Shahpiri, Z., R. Bahramsoltani, M. H. Farzaei, F. Farzaei, and R. Rahimi. 2016. Phytochemicals as future drugs for Parkinson’s disease: A comprehensive review. Reviews in the Neurosciences 27 (6):651–668.
  • Shang, H.-S., C.-H. Chang, Y.-R. Chou, M.-Y. Yeh, M.-K. Au, H.-F. Lu, Y.-L. Chu, H.-M. Chou, H.-C. Chou, Y.-L. Shih, and J.-G. Chung. 2016a. Curcumin causes DNA damage and affects associated protein expression in HeLa human cervical cancer cells. Oncology Reports 36 (4):2207–2215. doi: 10.3892/or.2016.5002.
  • Shang, W., L. J. Zhao, X. L. Dong, Z. M. Zhao, J. Li, B. B. Zhang, and H. Cai. 2016b. Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways. Molecular Medicine Reports 14 (4):3620–3626. doi: 10.3892/mmr.2016.5674.
  • Shankar, T. B., N. Shantha, H. Ramesh, I. A. Murthy, and V. S. Murthy. 1980. Toxicity studies on turmeric (Curcuma longa): Acute toxicity studies in rats, guineapigs and monkeys. Indian Journal of Experimental Biology 18:73–75.
  • Shanmugam, M. K., G. Rane, M. M. Kanchi, F. Arfuso, A. Chinnathambi, M. Zayed, S. A. Alharbi, B. K. Tan, A. P. Kumar, and G. Sethi. 2015. The multifaceted role of curcumin in cancer prevention and treatment. Molecules (Basel, Switzerland) 20 (2):2728–2769.
  • Sharma, A. V., K. Ganguly, S. Paul, N. Maulik, and S. Swarnakar. 2012. Curcumin heals indomethacin-induced gastric ulceration by stimulation of angiogenesis and restitution of collagen fibers via VEGF and MMP-2 mediated signaling. Antioxidants & Redox Signaling 16:351–362. doi: 10.1089/ars.2011.4232.
  • Sharma, M., R. Manoharlal, N. Puri, and R. Prasad. 2010. Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans. Bioscience Reports 30 (6):391–404. doi: 10.1042/BSR20090151.
  • Sharma, R. A., H. R. McLelland, K. A. Hill, C. R. Ireson, S. A. Euden, M. M. Manson, M. Pirmohamed, L. J. Marnett, A. J. Gescher, and W. P. Steward. 2001. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clinical Cancer Research 7:1894–1900.
  • Sharma, R. A., S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan, D. Hemingway, and S. M. Plummer. 2004. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clinical Cancer Research 10 (20):6847–6854.
  • Sharma, S., K. Chopra, and S. K. Kulkarni. 2007. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: Participation of nitric oxide and TNF‐alpha. Phytotherapy Research 21 (3):278–283.
  • Sharma, S., S. K. Kulkarni, J. N. Agrewala, and K. Chopra. 2006. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. European Journal of Pharmacology 536 (3):256–261. doi: 10.1016/j.ejphar.2006.03.006.
  • Sharma, V., A. Jha, A. Kumar, A. Bhatnagar, G. Narayan, and J. Kaur. 2014. Curcumin-mediated reversal of p15 gene promoter methylation: Implication in anti-neoplastic action against acute lymphoid leukaemia cell line. Folia Biologica 61:81–89.
  • Shi, Q., X. Le, J. L. Abbruzzese, Z. Peng, C. N. Qian, H. Tang, Q. Xiong, B. Wang, X. C. Li, and K. Xie. 2001. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Research 61 (10):4143–4154.
  • Shoskes, D., C. Lapierre, M. Cruz-Corerra, N. Muruve, R. Rosario, B. Fromkin, M. Braun, and J. Copley. 2005. Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: A randomized placebo controlled trial. Transplantation 80 (11):1556–1559.
  • Shukla, P. K., V. K. Khanna, M. M. Ali, M. Y. Khan, and R. C. Srimal. 2008. Anti-ischemic effect of curcumin in rat brain. Neurochemical Research 33 (6):1036–1043.
  • Si, X., B. M. McManus, J. Zhang, J. Yuan, C. Cheung, M. Esfandiarei, A. Suarez, A. Morgan, and H. Luo. 2005. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway. Journal of Virology 79 (13):8014–8023.
  • Si, X., Y. Wang, J. Wong, J. Zhang, B. M. McManus, and H. Luo. 2007. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. Journal of Virology 81 (7):3142–3150.
  • Siddappa, G., S. Kulsum, D. R. Ravindra, V. V. Kumar, N. Raju, N. Raghavan, H. V. Sudheendra, A. Sharma, S. P. Sunny, T. Jacob, et al. 2017. Curcumin and metformin mediated chemoprevention of oral cancer is associated with inhibition of cancer stem cells. Molecular Carcinogenesis 56 (11):2446–2460.,
  • Singh, M., and N. Singh. 2009. Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Molecular and Cellular Biochemistry 325 (1–2):107–119. doi: 10.1007/s11010-009-0025-5.
  • Singh, M., and N. Singh. 2011. Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells. Molecular and Cellular Biochemistry 347 (1–2):1–11. doi: 10.1007/s11010-010-0606-3.
  • Singh, S., and P. Kumar. 2016. Neuroprotective activity of curcumin in combination with piperine against quinolinic acid induced neurodegeneration in rats. Pharmacology 97 (3–4):151–160.
  • Singh, S., and P. Kumar. 2017. Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats. Inflammopharmacology 25 (1):69–79.
  • Singla, V., V. Pratap Mouli, S. K. Garg, T. Rai, B. N. Choudhury, P. Verma, R. Deb, V. Tiwari, S. Rohatgi, R. Dhingra, et al. 2014. Induction with NCB-02 (curcumin) enema for mild-tomoderate distal ulcerative colitis-a randomized, placebo-controlled, pilot study. Journal of Crohn’s and Colitis 8 (3):208–214., doi: 10.1016/j.crohns.2013.08.006.
  • Siviero, A., E. Gallo, V. Maggini, L. Gori, A. Mugelli, F. Firenzuoli, and A. Vannacci. 2015. Curcumin, a golden spice with a low bioavailability. Journal of Herbal Medicine 5 (2):57–70.
  • Soleimani, V., A. Sahebkar, and H. Hosseinzadeh. 2018. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances. Phytotherapy Research 32 (6):985–995. doi: 10.1002/ptr.6054.
  • Song, F., L. Zhang, H. X. Yu, R. R. Lu, J. D. Bao, C. Tan, and Z. Sun. 2012. The mechanism underlying proliferation-inhibitory and apoptosis-inducing effects of curcumin on papillary thyroid cancer cells. Food Chemistry 132 (1):43–50. doi: 10.1016/j.foodchem.2011.10.024.
  • Soni, K., and R. Kuttan. 1992. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian Journal of Physiology and Pharmacology 36:273–273.
  • Su, C. C., M. J. Wang, and T. L. Chiu. 2010. The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma. International Journal of Molecular Medicine 26:217–224.
  • Subudhi, U., and G. B. Chainy. 2010. Expression of hepatic antioxidant genes in l-thyroxineinduced hyperthyroid rats: Regulation by vitamin E and curcumin. Chemico-Biological Interactions 183 (2):304–316.
  • Subudhi, U., and G. Chainy. 2012. Curcumin and vitamin E modulate hepatic antioxidant gene expression in PTU-induced hypothyroid rats. Molecular Biology Reports 39 (11):9849–9861. doi: 10.1007/s11033-012-1851-1.
  • Subudhi, U., K. Das, B. Paital, S. Bhanja, and G. B. Chainy. 2009. Supplementation of curcumin and vitamin E enhances oxidative stress, but restores hepatic histoarchitecture in hypothyroid rats. Life Sciences 84 (11–12):372–379. doi: 10.1016/j.lfs.2008.12.024.
  • Subudhi, U., K. Das, B. Paital, S. Bhanja, and G. Chainy. 2008. Alleviation of enhanced oxidative stress and oxygen consumption of L-thyroxine induced hyperthyroid rat liver mitochondria by vitamin E and curcumin. Chemico-Biological Interactions 173 (2):105–114. doi: 10.1016/j.cbi.2008.02.005.
  • Sudheeran, S. P., D. Jacob, J. N. Mulakal, G. G. Nair, A. Maliakel, B. Maliakel, R. Kuttan, and I. Krishnakumar. 2016. Safety, tolerance, and enhanced efficacy of a bioavailable formulation of curcumin with fenugreek dietary fiber on occupational stress: A randomized, double-blind, placebo-controlled pilot study. Journal of Clinical Psychopharmacology 36:236–243.
  • Sui, Z., R. Salto, J. Li, C. Craik, and P. R. O. de Montellano. 1993. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorganic & Medicinal Chemistry 1:415–422.
  • Sun, C. Y., S. S. Qi, P. Zhou, H. R. Cui, S. X. Chen, K. Y. Dai, and M. L. Tang. 2013a. Neurobiological and pharmacological validity of curcumin in ameliorating memory performance of senescence-accelerated mice. Pharmacology Biochemistry and Behavior 105:76–82. doi: 10.1016/j.pbb.2013.02.002.
  • Sun, J., Y. Zhao, and J. Hu. 2013. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice. PLoS One 8 (6):e67078. doi: 10.1371/journal.pone.0067078.
  • Sun, Y., J. Zhang, J. Zhou, Z. Huang, H. Hu, M. Qiao, X. Zhao, and D. Chen. 2015. Synergistic effect of cucurbitacin B in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells. European Journal of Pharmacology 768:28–40.
  • Sun, Y., W. Liu, H. Zhang, H. Li, J. Liu, F. Zhang, T. Jiang, and S. Jiang. 2017. Curcumin prevents osteoarthritis by inhibiting the activation of inflammasome NLRP3. Journal of Interferon & Cytokine Research 37:449–455. doi: 10.1089/jir.2017.0069.
  • Suresh, D., and K. Srinivasan. 2010. Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats. Indian Journal of Medical Research 131:682–691.
  • Tamagno, E., M. Parola, P. Bardini, A. Piccini, R. Borghi, M. Guglielmotto, G. Santoro, A. Davit, O. Danni, M. A. Smith, et al. 2005. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. Journal of Neurochemistry 92 (3):628–636. doi: 10.1111/j.1471-4159.2004.02895.x.
  • Tan, C., L. Zhang, X. Cheng, X. F. Lin, R. R. Lu, J. D. Bao, and H. X. Yu. 2015. Curcumin inhibits hypoxia-induced migration in K1 papillary thyroid cancer cells. Experimental Biology and Medicine 240 (7):925–935. doi: 10.1177/1535370214555665.
  • Taverna, S., M. Giallombardo, M. Pucci, A. Flugy, M. Manno, S. Raccosta, C. Rolfo, G. De Leo, and R. Alessandro. 2015. Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: A possible role for exosomal disposal of miR-21. Oncotarget 6:21918–21933.
  • Teow, S. Y., K. Liew, S. A. Ali, A. S. B. Khoo, and S. C. Peh. 2016. Antibacterial action of curcumin against Staphylococcus aureus: A brief review. Journal of Tropical Medicine 2016:1. doi: 10.1155/2016/2853045.
  • Thacker, P. C., and D. Karunagaran. 2015. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells. PLoS One 10 (3):e0120045.
  • Thangapazham, R. L., A. Sharma, and R. K. Maheshwari. 2007. Beneficial role of curcumin in skin diseases. In The molecular targets and therapeutic uses of curcumin in health and disease, edited by B. B. Aggarwal, Y.-J. Surh, and S. Shishodia, 343–357. Boston, MA: Springer.
  • Tian, B., Y. Zhao, T. Liang, X. Ye, Z. Li, D. Yan, Q. Fu, and Y. Li. 2017. Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K/AKT/mTOR signaling pathway. Journal of Drug Targeting 25 (7):626–636. doi: 10.1080/1061186X.2017.1306535.
  • Tian, M., X. Zhang, L. Wang, and Y. Li. 2013. Curcumin induces ABCA1 expression and apolipoprotein AI-mediated cholesterol transmembrane in the chronic cerebral hypoperfusion aging rats. The American Journal of Chinese Medicine 41 (5):1027–1042. doi: 10.1142/S0192415X13500699.
  • Tong, S. Y., J. S. Davis, E. Eichenberger, T. L. Holland, and V. G. Fowler. 2015. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Reviews 28 (3):603–661. doi: 10.1128/CMR.00134-14.
  • Tong, W., Q. Wang, D. Sun, and J. Suo. 2016. Curcumin suppresses Colon cancer cell invasion via AMPK-induced inhibition of NF-κB, uPA activator and MMP9. Oncology Letters 12 (5):4139–4146. doi: 10.3892/ol.2016.5148.
  • Topcu-Tarladacalisir, Y., M. Sapmaz-Metin, and T. Karaca. 2016. Curcumin counteracts cisplatin induced nephrotoxicity by preventing renal tubular cell apoptosis. Renal Failure 38 (10):1741–1748. doi: 10.1080/0886022X.2016.1229996.
  • Torella, M., F. Del Deo, A. Grimaldi, S. Iervolino, M. Pezzella, C. Tammaro, P. Gallo, C. Rappa, P. De Franciscis, and N. Colacurci. 2016. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. European Journal of Obstetrics & Gynecology and Reproductive Biology 207:125–128.
  • Tripanichkul, W., and E. Jaroensuppaperch. 2013. Ameliorating effects of curcumin on 6-OHDAinduced dopaminergic denervation, glial response, and SOD1 reduction in the striatum of hemiparkinsonian mice. European Review for Medical and Pharmacological Sciences 17:1360–1368.
  • Tu, Y., D. Sun, X. Zeng, N. Yao, X. Huang, D. Huang, and Y. Chen. 2014. Piperine potentiates the hypocholesterolemic effect of curcumin in rats fed on a high fat diet. Experimental and Therapeutic Medicine 8 (1):260–266.
  • Tyagi, P., M. Singh, H. Kumari, A. Kumari, and K. Mukhopadhyay. 2015. Bactericidal activity of curcumin I is associated with damaging of bacterial membrane. PLoS One 10 (3):e0121313. doi: 10.1371/journal.pone.0121313.
  • Um, M. Y., K. H. Hwang, W. H. Choi, J. Ahn, C. H. Jung, and T. Y. Ha. 2014. Curcumin attenuates adhesion molecules and matrix metalloproteinase expression in hypercholesterolemic rabbits. Nutrition Research 34 (10):886–893. doi: 10.1016/j.nutres.2014.09.001.
  • Umar, S., M. A. A. Shah, M. T. Munir, M. Yaqoob, M. Fiaz, S. Anjum, K. Kaboudi, M. Bouzouaia, M. Younus, Q. Nisa, et al. 2016. Synergistic effects of thymoquinone and curcumin on immune response and anti-viral activity against avian influenza virus (H9N2) in turkeys. Poultry Science 95 (7):1513–1520.
  • Vallianou, N. G., A. Evangelopoulos, N. Schizas, and C. Kazazis. 2015. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Research 35:645–651.
  • Vaughn, A. R., A. Branum, and R. K. Sivamani. 2016. Effects of turmeric (Curcuma longa) on skin health: A systematic review of the clinical evidence. Phytotherapy Research 30 (8):1243–1264. doi: 10.1002/ptr.5640.
  • Vizzutti, F., A. Provenzano, S. Galastri, S. Milani, W. Delogu, E. Novo, A. Caligiuri, E. Zamara, U. Arena, G. Laffi, et al. 2010. Curcumin limits the fibrogenic evolution of experimental steatohepatitis. Laboratory Investigation 90 (1):104–115., doi: 10.1038/labinvest.2009.112.
  • Waghmare, P., A. Chaudhari, V. Karhadkar, and A. Jamkhande. 2011. Comparative evaluation of turmeric and chlorhexidinegluconate mouthwash in prevention of plaque formation and gingivitis: A clinical and microbiological study. The Journal of Contemporary Dental Practice 12:221–224.
  • Wan, P., H. Chen, Y. Guo, and A. P. Bai. 2014. Advances in treatment of ulcerative colitis with herbs: From bench to bedside. World Journal of Gastroenterology 20 (39):14099–14104.
  • Wan, Q., Z. Y. Liu, Y. P. Yang, and S. M. Liu. 2016. Effect of curcumin on inhibiting atherogenesis by down-regulating lipocalin-2 expression in apolipoprotein E knockout mice. BioMedical Materials and Engineering 27:577–587.
  • Wang, J., X. Zhou, W. Li, X. Deng, Y. Deng, and X. Niu. 2016a. Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-assembly process of α-hemolysin. Scientific Reports 6:28254. doi:10.1038/srep28254.
  • Wang, K., C. Zhang, J. Bao, X. Jia, Y. Liang, X. Wang, M. Chen, H. Su, P. Li, J.-B. Wan, and C. He. 2016b. Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Scientific Reports 6:26064.
  • Wang, N. P., Z. F. Wang, S. Tootle, T. Philip, and Z. Q. Zhao. 2012. Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction. British Journal of Pharmacology 167 (7):1550–1562. doi: 10.1111/j.1476-5381.2012.02109.x.
  • Wang, P., C. Su, R. Li, H. Wang, Y. Ren, H. Sun, J. Yang, J. Sun, J. Shi, J. Tian, and S. Jiang. 2014. Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice. Journal of Neuroscience Research 92 (2):218–231.
  • Wang, X., L. Wang, H. Zhang, K. Li, and J. You. 2016c. Ultrastructural changes during lung carcinogenesis-modulation by curcumin and quercetin. Oncology Letters 12 (6):4357–4360. doi: 10.3892/ol.2016.5259.
  • Wang, X., Y. Hang, J. Liu, Y. Hou, N. Wang, and M. Wang. 2017. Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell. Oncology Letters 13 (6):4825–4831. doi: 10.3892/ol.2017.6053.
  • Wang, Y., J. Yu, R. Cui, J. Lin, and X. Ding. 2016d. Curcumin in treating breast cancer: A review. Journal of Laboratory Automation 21 (6):723–731.
  • Wei, Z. Q., Y. H. Zhang, C. Z. Ke, H. X. Chen, P. Ren, Y. L. He, P. Hu, D. Q. Ma, J. Luo, and Z. J. Meng. 2017. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNAbound histone acetylation. World Journal of Gastroenterology 23 (34):6252–6260. doi: 10.3748/wjg.v23.i34.6252.
  • Wilken, R., M. S. Veena, M. B. Wang, and E. S. Srivatsan. 2011. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Molecular Cancer 10 (1):12. doi: 10.1186/1476-4598-10-12.
  • Wongcharoen, W., and A. Phrommintikul. 2009. The protective role of curcumin in cardiovascular diseases. International Journal of Cardiology 133 (2):145–151.
  • Wongcharoen, W., S. Jai-Aue, A. Phrommintikul, W. Nawarawong, S. Woragidpoonpol, T. Tepsuwan, A. Sukonthasarn, N. Apaijai, and N. Chattipakorn. 2012. Effects of curcuminoids on frequency of acute myocardial infarction after coronary artery bypass grafting. The American Journal of Cardiology 110 (1):40–44. doi: 10.1016/j.amjcard.2012.02.043.
  • Wu, B., X. Yao, X. Nie, and R. Xu. 2013a. Epigenetic reactivation of RANK in glioblastoma cells by curcumin: Involvement of STAT3 inhibition. DNA and Cell Biology 32:292–297.
  • Wu, G.-Q., K.-Q. Chai, X.-M. Zhu, H. Jiang, X. Wang, Q. Xue, A.-H. Zheng, H.-Y. Zhou, Y. Chen, X.-C. Chen, et al. 2016. Anti-cancer effects of curcumin on lung cancer through the inhibition of EZH2 and NOTCH1. Oncotarget 7 (18):26535–26550.,
  • Wu, J., Q. Li, X. Wang, S. Yu, L. Li, X. Wu, Y. Chen, J. Zhao, and Y. Zhao. 2013b. Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. PLoS One 8 (3):e59843.
  • Wu, J., W. Y. Lu, and L. L. Cui. 2015. Inhibitory effect of curcumin on invasion of skin squamous cell carcinoma A431 cells. Asian Pacific Journal of Cancer Prevention: APJCP 16 (7):2813–2818.
  • Wu, S., and D. Xiao. 2016. Effect of curcumin on nasal symptoms and airflow in patients with perennial allergic rhinitis. Annals of Allergy, Asthma & Immunology 117:697–702. doi: 10.1016/j.anai.2016.09.427.
  • Xiao, J., X. Sheng, X. Zhang, M. Guo, and X. Ji. 2016. Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro. Drug Design, Development and Therapy 10:1267–1277.
  • Xie, Y. L., J. G. Chu, X. M. Jian, J. Z. Dong, L. P. Wang, G. X. Li, and N. B. Yang. 2017. Curcumin attenuates lipopolysaccharide/d-galactosamine-induced acute liver injury by activating Nrf2 nuclear translocation and inhibiting NF-kB activation. Biomedicine & Pharmacotherapy 91:70–77. doi: 10.1016/j.biopha.2017.04.070.
  • Xin, M., Y. Yang, D. Zhang, J. Wang, S. Chen, and D. Zhou. 2015. Attenuation of hind-limb suspension-induced bone loss by curcumin is associated with reduced oxidative stress and increased vitamin D receptor expression. Osteoporosis International 26 (11):2665–2676. doi: 10.1007/s00198-015-3153-7.
  • Xiong, Z., Z. Hongmei, S. Lu, and L. Yu. 2011. Curcumin mediates presenilin-1 activity to reduce beta-amyloid production in a model of Alzheimer’s disease. Pharmacological Reports 63 (5):1101–1108. doi: 10.1016/S1734-1140(11)70629-6.
  • Xu, B., L. Yu, and L. Z. Zhao. 2017. Curcumin up regulates T helper 1 cells in patients with Colon cancer. American Journal of Translational Research 9:1866–1875.
  • Xu, F., R. Diao, J. Liu, Y. Kang, X. Wang, and L. Shi. 2015. Curcumin attenuates staphylococcus aureus‐induced acute lung injury. The Clinical Respiratory Journal 9 (1):87–97. doi: 10.1111/crj.12113.
  • Xu, X., J. Qin, and W. Liu. 2014. Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/Akt signaling pathway. Gene 546 (2):226–232.
  • Yadav, S. K., A. K. Sah, R. K. Jha, P. Sah, and D. K. Shah. 2013. Turmeric (curcumin) remedies gastroprotective action. Pharmacognosy Reviews 7:42–46. doi: 10.4103/0973-7847.112843.
  • Yang, C., X. Ma, Z. Wang, X. Zeng, Z. Hu, Z. Ye, and G. Shen. 2017a. Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation. Drug Design, Development and Therapy 11:431–439. doi: 10.2147/DDDT.S126964.
  • Yang, C., X. Zhang, H. Fan, and Y. Liu. 2009. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Research 1282:133–141. doi: 10.1016/j.brainres.2009.05.009.
  • Yang, C.W., C.L. Chang, H.C. Lee, C.W. Chi, J.P. Pan, and W.C. Yang. 2012. Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK pathways. BMC Complementary and Alternative Medicine 12:22. doi:10.1186/1472-6882-12-22.
  • Yang, F., G. P. Lim, A. N. Begum, O. J. Ubeda, M. R. Simmons, S. S. Ambegaokar, P. P. Chen, R. Kayed, C. G. Glabe, S. A. Frautschy, and G. M. Cole. 2005. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. Journal of Biological Chemistry 280 (7):5892–5901. doi: 10.1074/jbc.M404751200.
  • Yang, J., C. Wang, Z. Zhang, X. Chen, Y. Jia, B. Wang, and T. Kong. 2017b. Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch‐1 signaling pathway. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 125 (2):134–140.
  • Yang, J., S. Song, J. Li, and T. Liang. 2014. Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson’s disease rat. Pathology-Research and Practice 210 (6):357–362. doi: 10.1016/j.prp.2014.02.005.
  • Yang, K., C. Xu, X. Li, and H. Jiang. 2013. Combination of D942 with curcumin protects cardiomyocytes from ischemic damage through promoting autophagy. Journal of Cardiovascular Pharmacology and Therapeutics 18 (6):570–581.
  • Yang, M., G. Lee, J. Si, S. J. Lee, H. J. You, and G. Ko. 2016. Curcumin shows antiviral properties against Norovirus. Molecules 21 (10):1401.
  • Yang, X. X., C. M. Li, and C. Z. Huang. 2016. Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. Nanoscale 8 (5):3040–3048.
  • Yang, X., J.-N. Lv, H. Li, B. Jiao, Q.-H. Zhang, Y. Zhang, J. Zhang, Y.-Q. Liu, M. Zhang, H. Shan, et al. 2017c. Curcumin reduces lung inflammation via Wnt/β-catenin signaling in mouse model of asthma. Journal of Asthma 54 (4):335–340., doi: 10.1080/02770903.2016.1218018.
  • Yang, Y., X. Wu, Z. Wei, Y. Dou, D. Zhao, T. Wang, D. Bian, B. Tong, Y. Xia, and Y. Xia. 2015. Oral curcumin has anti-arthritic efficacy through somatostatin generation via cAMP/PKA and Ca 2+/CaMKII signaling pathways in the small intestine. Pharmacological Research 95:71–81. doi: 10.1016/j.phrs.2015.03.016.
  • Yao, Y., W. Wang, M. Li, H. Ren, C. Chen, J. Wang, W. E. Wang, J. Yang, and C. Zeng. 2016. Curcumin exerts its anti-hypertensive effect by down-regulating the AT1 receptor in vascular smooth muscle cells. Scientific Reports 6:25579. doi:10.1038/srep25579.
  • Ye, M., H. Qiu, Y. Cao, M. Zhang, Y. Mi, J. Yu, and C. Wang. 2017. Curcumin improves palmitate-induced insulin resistance in human umbilical vein endothelial cells by maintaining proteostasis in endoplasmic reticulum. Frontiers in Pharmacology 8 (148). doi:10.3389/fphar.2017.00148.
  • Yildirim, H., F. B. Sunay, S. Sinan, and F. Köçkar. 2016. In vivo effects of curcumin on the paraoxonase, carbonic anhydrase, glucose-6-phosphate dehydrogenase and β-glucosidase enzyme activities in dextran sulphate sodium-induced ulcerative colitis mice. Journal of Enzyme Inhibition and Medicinal Chemistry 31:1583–1590.
  • Yodkeeree, S., C. Ampasavate, B. Sung, B. B. Aggarwal, and P. Limtrakul. 2010. Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. European Journal of Pharmacology 627 (1–3):8–15. doi: 10.1016/j.ejphar.2009.09.052.
  • Yoysungnoen-Chintana, P., P. Bhattarakosol, and S. Patumraj. 2014. Antitumor and antiangiogenic activities of curcumin in cervical cancer xenografts in nude mice. BioMed Research International 2014:1. doi: 10.1155/2014/817972.
  • Yu, J., Y. Peng, L.-C. Wu, Z. Xie, Y. Deng, T. Hughes, S. He, X. K. Mo, M. Chiu, Q.-E. Wang, et al. 2013. Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. PLoS One 8 (2):e55934
  • Yu, S., X. Wang, X. He, Y. Wang, S. Gao, L. Ren, and Y. Shi. 2016. Curcumin exerts antiinflammatory and antioxidative properties in 1-methyl-4-phenylpyridinium ion (MPP+)stimulated mesencephalic astrocytes by interference with TLR4 and downstream signaling pathway. Cell Stress and Chaperones 21 (4):697–705. doi: 10.1007/s12192-016-0695-3.
  • Yu, Y., S. Wu, J. Li, R. Wang, X. Xie, X. Yu, J. Pan, Y. Xu, and L. Zheng. 2015. The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: Involvement of 5-HT-dependent signaling. Metabolic Brain Disease 30 (1):47–55. doi: 10.1007/s11011-014-9554-z.
  • Yue, G. G.-L., H.-F. Kwok, J. K.-M. Lee, L. Jiang, E. C.-W. Wong, S. Gao, H.-L. Wong, L. Li, K.-M. Chan, P.-C. Leung, et al. 2016. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in Colon cancer mice. Pharmacological Research 111:43–57.,
  • Zaky, A., A. Bassiouny, M. Farghaly, and B. M. El-Sabaa. 2017. A combination of resveratrol and curcumin is effective against aluminum chloride-induced neuroinflammation in rats. Journal of Alzheimer’s Disease 60 (s1):S221–S235.
  • Zaky, A., M. Mahmoud, D. Awad, B. M. El Sabaa, K. M. Kandeel, and A. R. Bassiouny. 2014. Valproic acid potentiates curcumin-mediated neuroprotection in lipopolysaccharide induced rats. Frontiers in Cellular Neuroscience 8:337. doi:10.3389/fncel.2014.00337.
  • Zaman, M. S., N. Chauhan, M. M. Yallapu, R. K. Gara, D. M. Maher, S. Kumari, M. Sikander, S. Khan, N. Zafar, and M. Jaggi. 2016. Curcumin nanoformulation for cervical cancer treatment. Scientific Reports 6:20051. doi:10.1038/srep20051.
  • Zandi, K., E. Ramedani, K. Mohammadi, S. Tajbakhsh, I. Deilami, Z. Rastian, M. Fouladvand, F. Yousefi, and F. Farshadpour. 2010. Evaluation of antiviral activities of curcumin derivatives against HSV-1 in vero cell line. Natural Product Communications 5:1935–1938.
  • Zanotto-Filho, A., E. Braganhol, M. I. Edelweiss, G. A. Behr, R. Zanin, R. Schroder, A. Simoes-Pires, A. M. Battastini, and J. C. Moreira. 2012. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. The Journal of Nutritional Biochemistry 23 (6):591–601. doi: 10.1016/j.jnutbio.2011.02.015.
  • Zeng, Y., G. Weng, J. Fan, Z. Li, J. Wu, Y. Li, R. Zheng, P. Xia, and K. Guo. 2016. Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells. Oncology Reports 36 (3):1233–1242.
  • Zhang, C. Y., L. Zhang, H. X. Yu, J. D. Bao, Z. Sun, and R. R. Lu. 2013a. Curcumin inhibits invasion and metastasis in K1 papillary thyroid cancer cells. Food Chemistry 139 (1–4):1021–1028. doi: 10.1016/j.foodchem.2013.02.016.
  • Zhang, D. W., M. Fu, S. H. Gao, and J. L. Liu. 2013b. Curcumin and diabetes: A systematic review. Evidence-Based Complementary and Alternative Medicine 2013:1. doi: 10.1155/2013/636053.
  • Zhang, J. Y., M. T. Lin, M. J. Zhou, T. Yi, Y. N. Tang, S. L. Tang, Z. J. Yang, Z. Z. Zhao, and H. B. Chen. 2015a. Combinational treatment of curcumin and quercetin against gastric cancer MGC-803 cells in vitro. Molecules 20 (6):11524–11534.
  • Zhang, L., J. Luo, M. Zhang, W. Yao, X. Ma, and S. Y. Yu. 2014. Effects of curcumin on chronic, unpredictable, mild, stress-induced depressive-like behaviour and structural plasticity in the lateral amygdala of rats. The International Journal of Neuropsychopharmacology 17 (5):793–806. doi: 10.1017/S1461145713001661.
  • Zhang, L., T. Xu, S. Wang, L. Yu, D. Liu, R. Zhan, and S. Y. Yu. 2013c. NMDA GluN2B receptors involved in the antidepressant effects of curcumin in the forced swim test. Progress in Neuro-Psychopharmacology and Biological Psychiatry 40:12–17. doi: 10.1016/j.pnpbp.2012.08.017.
  • Zhang, L., X. Cheng, Y. Gao, C. Zhang, J. Bao, H. Guan, H. Yu, R. Lu, Q. Xu, and Y. Sun. 2016a. Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-beta/Smad2/3 signaling pathway. Experimental Cell Research 341 (2):157–165. doi: 10.1016/j.yexcr.2016.01.006.
  • Zhang, L., X. Cheng, Y. Gao, J. Bao, H. Guan, R. Lu, H. Yu, Q. Xu, and Y. Sun. 2016b. Induction of ROS-independent DNA damage by curcumin leads to G2/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells. Food & Function 7:315–325. doi: 10.1039/C5FO00681C.
  • Zhang, M., Y. Xie, R. Yan, H. Shan, J. Tang, Y. Cai, J. Yin, M. Chen, J. Zhang, X. Yang, et al. 2016c. Curcumin ameliorates alveolar epithelial injury in a rat model of chronic obstructive pulmonary disease. Life Sciences 164:1–8., doi: 10.1016/j.lfs.2016.09.001.
  • Zhang, N., H. Li, J. Jia, and M. He. 2015b. Anti-inflammatory effect of curcumin on mast cellmediated allergic responses in ovalbumin-induced allergic rhinitis mouse. Cellular Immunology 298 (1–2):88–95. doi: 10.1016/j.cellimm.2015.09.010.
  • Zhang, P., and X. Zhang. 2018. Stimulatory effects of curcumin and quercetin on posttranslational modifications of p53 during lung carcinogenesis. Human & Experimental Toxicology 37:618–625.
  • Zhang, Z., H. Chen, C. Xu, L. Song, L. Huang, Y. Lai, Y. Wang, H. Chen, D. Gu, L. Ren, and Q. Yao. 2016d. Curcumin inhibits tumor epithelial-mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in Colon cancer cells. Oncology Reports 35 (5):2615–2623. doi: 10.3892/or.2016.4669.
  • Zhao, G., X. Han, S. Zheng, Z. Li, Y. Sha, J. Ni, Z. Sun, S. Qiao, and Z. Song. 2016a. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells. Oncology Reports 35 (2):1065–1074. doi: 10.3892/or.2015.4413.
  • Zhao, H. M., R. Xu, X. Y. Huang, S. M. Cheng, M. F. Huang, H. Y. Yue, X. Wang, Y. Zou, A. P. Lu, and D. Y. Liu. 2016b. Curcumin improves regulatory T cells in gut-associated lymphoid tissue of colitis mice. World Journal of Gastroenterology 22 (23):5374–5383. doi: 10.3748/wjg.v22.i23.5374.
  • Zhao, J., S. Yu, W. Zheng, G. Feng, G. Luo, L. Wang, and Y. Zhao. 2010. Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochemical Research 35 (3):374–379. doi: 10.1007/s11064-009-0065-y.
  • Zhao, Z., C. Li, H. Xi, Y. Gao, and D. Xu. 2015. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway. Molecular Medicine Reports 12 (4):5415–5422. doi: 10.3892/mmr.2015.4060.
  • Zheng, R., Z. You, J. Jia, S. Lin, S. Han, A. Liu, H. Long, and S. Wang. 2016. Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells. Molecular Medicine Reports 13 (2):1570–1576.
  • Zhou, D.-Y., K. Zhang, A. H. Conney, N. Ding, X.-X. Cui, H. Wang, M. Verano, S.-Q. Zhao, Y.-X. Fan, X. Zheng, and Z.-Y. Du. 2013. Synthesis and evaluation of curcumin-related compounds containing benzyl piperidone for their effects on human cancer cells. Chemical and Pharmaceutical Bulletin 61 (11):1149–1155. doi: 10.1248/cpb.c13-00507.
  • Zhou, H., C. S. Beevers, and S. Huang. 2011. The targets of curcumin. Current Drug Targets 12 (3):332–347.
  • Zhou, M., Z. Li, Z. Han, and N. Tian. 2015. Paclitaxel-sensitization enhanced by curcumin involves down-regulation of nuclear factor-κ B and Lin28 in Hep3B cells. Journal of Receptors and Signal Transduction 35 (6):618–625.
  • Zhu, G. H., H. P. Dai, Q. Shen, O. Ji, Q. Zhang, and Y. L. Zhai. 2016. Curcumin induces apoptosis and suppresses invasion through MAPK and MMP signaling in human monocytic leukemia SHI-1 cells. Pharmaceutical Biology 54:1303–1311. doi: 10.3109/13880209.2015.1060508.
  • Zhu, J.-Y., X. Yang, Y. Chen, Y. Jiang, S.-J. Wang, Y. Li, X.-Q. Wang, Y. Meng, M.-M. Zhu, X. Ma, et al. 2017. Curcumin suppresses lung cancer stem cells via inhibiting wnt/β‐catenin and sonic hedgehog pathways. Phytotherapy Research 31 (4):680–688., doi: 10.1002/ptr.5791.
  • Zhu, W., J. Su, J. Liu, and C. Jiang. 2015. The involvement of neuronal nitric oxide synthase in the anti-epileptic action of curcumin on pentylenetetrazol-kindled rats. Bio-Medical Materials and Engineering 26 (s1):S841–S850. doi: 10.3233/BME-151376.
  • Zorofchian Moghadamtousi, S., H. Abdul Kadir, P. Hassandarvish, H. Tajik, S. Abubakar, and K. Zandi. 2014. A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed Research International 2014:1. doi: 10.1155/2014/186864.
  • Zuccotti, G., D. Trabattoni, M. Morelli, S. Borgonovo, L. Schneider, and M. Clerici. 2008. Immune modulation by lactoferrin and curcumin in children with recurrent respiratory infections. Journal of Biological Regulators and Homeostatic Agents 23:119–123.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.